Compound having 2,2-difluorovinyloxy group or 1,2,2-trifluorovinyloxy group, liquid crystal composition and liquid crystal display device

Information

  • Patent Grant
  • 9273245
  • Patent Number
    9,273,245
  • Date Filed
    Monday, July 1, 2013
    11 years ago
  • Date Issued
    Tuesday, March 1, 2016
    8 years ago
Abstract
To provide a liquid crystal compound having a high stability to light, a high clearing point, a low minimum temperature of a liquid crystal phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy, a suitable elastic constant and an excellent solubility in other liquid crystal compounds. The invention concerns a compound represented by formula (1), a liquid crystal composition containing the compound and a liquid crystal display device including the composition:
Description
TECHNICAL FIELD

The invention relates to a liquid crystal compound and a liquid crystal composition. More specifically, the invention relates to a compound having a 2,2-difluorovinyloxy group or a 1,2,2-trifluorovinyloxy group, a liquid crystal composition containing the compound and having a nematic phase, and a liquid crystal display device including the composition.


BACKGROUND ART

A liquid crystal display device is widely utilized for a display of a personal computer, a television and so forth. The device utilizes optical anisotropy, dielectric anisotropy or the like of the liquid crystal compound. As an operating mode of the liquid crystal display device, various modes are known, such as a phase change (PC) mode, a twisted nematic (TN) mode, a super twisted nematic (STN) mode, a bistable twisted nematic (BTN) mode, an electrically controlled birefringence (ECB) mode, an optically compensated bend (OCB) mode, an in-plane switching (IPS) mode, a vertical alignment (VA) mode and a polymer sustained alignment (PSA) mode.


In such a liquid crystal display device, a liquid crystal composition having suitable physical properties is used. In order to further improve characteristics of the liquid crystal display device, the liquid crystal compound contained in the composition preferably has physical properties as represented in (1) to (8) below:


(1) high stability to heat, light and so forth;


(2) high clearing point;


(3) low minimum temperature of a liquid crystal phase;


(4) small viscosity (η);


(5) suitable optical anisotropy (Δn);


(6) large dielectric anisotropy (Δ∈);


(7) suitable elastic constant (K); and


(8) excellent solubility in other liquid crystal compounds.


An effect of the physical properties of the liquid crystal compound on the characteristics of the device is as described below. A compound having a high stability to heat, light and so forth as described in (1) increases a voltage holding ratio of the device. Thus, a service life of the device becomes long. A compound having a high clearing point as described in (2) extends a temperature range in which the device can be used. A compound having a low minimum temperature of a liquid crystal phase such as a nematic phase or a smectic phase as described in (3), particularly, a compound having a low minimum temperature of the nematic phase also extends the temperature range in which the device can be used. A compound having a small viscosity as described in (4) shortens a response time of the device.


A compound having a suitable optical anisotropy as described in (5) improves a contrast of the display device. According to a design of the display device, a compound having a large optical anisotropy or small optical anisotropy, more specifically, a compound having a suitable optical anisotropy is required. When shortening a response time by decreasing a cell gap of the display device, a compound having a large optical anisotropy is suitable. A compound having a large dielectric anisotropy as described in (6) decreases a threshold voltage of the display device. Thus, an electric power consumption of the display device becomes small. On the one hand, a compound having a small dielectric anisotropy, decreases a viscosity of the composition, and thus shortens a response time of the device.


With regard to (7), a compound having a large elastic constant shortens a response time of the display device. A compound having a small elastic constant decreases a threshold voltage of the display device. Accordingly, a suitable elastic constant is required according to characteristics to be desirably improved. A compound having an excellent solubility in other liquid crystal compounds as described in (8) is preferred. The reason is that physical properties of the composition are adjusted by mixing liquid crystal compounds having different physical properties.


Various kinds of liquid crystal compounds having a large dielectric anisotropy have been synthesized so far. The reason is that excellent physical properties that are not developed by a conventional compound are expected. The reason is that a suitable balance between two of physical properties required upon preparing the liquid crystal composition is expected for a new compound. Patent literature Nos. 1 to 7 describe a linear and cyclic compound having 2,2-difluorovinyloxy group.

  • Patent literature No. 8 describes a linear and cyclic compound (S-1) having a 1,3-dioxane ring.
  • Patent literature Nos. 9 to 12 describe compounds (S-2) to (S-5) having a CF2O bonding group and having a 2,2-difluorovinyloxy group.
  • Patent literature Nos. 13 to 14 describe compounds (S-6) to (S-7) having a bonding group other than a CF2O bonding group, and having a 2,2-difluorovinyloxy group.
  • Patent literature No. 15 describes compound (S-8).




embedded image


In view of such a situation, a development is desired for a compound having excellent physical properties and a suitable balance with regard to the physical properties described in (1) to (8).


CITATION LIST
Patent Literature



  • Patent literature No. 1: DE 4445224 A.

  • Patent literature No. 2: DE 4428766 A.

  • Patent literature No. 3: DE 102008004062 A.

  • Patent literature No. 4: DE 4326020 A.

  • Patent literature No. 5: DE 102009013710 A.

  • Patent literature No. 6: WO 2010/105730 A.

  • Patent literature No. 7: DE 4434976 A.

  • Patent literature No. 8: DE 19525314 A.

  • Patent literature No. 9: DE 102011011268 A.

  • Patent literature No. 10: DE 19531165 A.

  • Patent literature No. 11: DE 102007009944 A.

  • Patent literature No. 12: DE 10061790 A.

  • Patent literature No. 13: WO 92/21734 A.

  • Patent literature No. 14: JP H8-040952 A.

  • Patent literature No. 15: JP H10-204016 A.



SUMMARY OF INVENTION
Technical Problem

A first object of the invention is to provide a liquid crystal compound having a high stability to light, a high clearing point, a low minimum temperature of a liquid crystal phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy, a suitable elastic constant and an excellent solubility in other liquid crystal compounds. The object is to provide a compound having a particularly large dielectric anisotropy. The object is to provide a compound having a particularly high clearing point. A second object is to provide a liquid crystal composition containing the compound and having a high maximum temperature of a nematic phase, a low minimum temperature of the nematic phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy and a suitable elastic constant. The object is to provide a liquid crystal composition having a suitable balance regarding at least two of characteristics. A third object is to provide a liquid crystal display device including the composition and having a wide temperature range in which the device can be used, a short response time, a large voltage holding ratio, a large contrast ratio and a long service life.


Solution to Problem

The invention concerns a compound represented by formula (1), a liquid crystal composition containing the compound, and a liquid crystal display device including the composition.




embedded image



wherein, in the formula,


R1 is alkyl having 1 to 20 carbons, and in the alkyl, at least one of —CH2— may be replaced by —O—, and at least one of —(CH2)2— may be replaced by —CH═CH—;


ring A1, ring A2 and ring A3 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4- in which hydrogen may be replaced by halogen, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl;


Z1 and Z3 are independently a single bond, —(CH2)2—, —CH═CH—, —CF2O—, —CH2O—, —CF═CF—, —(CH2)2CF2O—, —CH═CHCF2O—, —CF2—O—(CH2)2—, —CF2OCH═CH—, —CH═CH—(CH2)2— or —(CH2)2—CH═CH—;


Z2 is —CF2O—;


L1, L2 and L3 are independently hydrogen or halogen; and


m and n are independently 0, 1, 2 or 3, and a sum of m and n is 0, 1, 2 or 3, and when m or n is 2 or 3, a plurality of ring A1 or ring A3 may be identical or different, and a plurality of Z1 or Z3 may be identical or different.


However, when ring A2 is 1,4-phenylene, or 1,4-phenylene in which one of hydrogen is replaced by halogen, m is 1 and n is 0, ring A1 is 1,4-phenylene in which hydrogen may be replaced by halogen, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl; and when a sum of m and n is 0, ring A2 is 1,4-cyclohexylene, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl.


The invention also concerns a liquid crystal composition containing the compound.


The invention further concerns a liquid crystal display device including the composition.


Advantageous Effects of Invention

A first advantage of the invention is to provide a liquid crystal compound having a high stability to light, a high clearing point, a low minimum temperature of a liquid crystal phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy, a suitable elastic constant and an excellent solubility in other liquid crystal compounds. The advantage is to provide a compound having a particularly large dielectric anisotropy. The advantage is to provide a compound having a particularly high clearing point. A second advantage is to provide a liquid crystal composition containing the compound and having a high maximum temperature of a nematic phase, a low minimum temperature of the nematic phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy and a suitable elastic constant. The advantage is to provide a liquid crystal composition having a suitable balance regarding at least two of characteristics. A third advantage is to provide a liquid crystal display device including the composition and having a wide temperature range in which the device can be used, a short response time, a large voltage holding ratio, a large contrast ratio and a long service life.







DESCRIPTION OF EMBODIMENTS

Usage of terms herein is as described below. “Liquid crystal compound” is a generic term for a compound having a liquid crystal phase such as a nematic phase or a smectic phase, and a compound having no liquid crystal phase but being useful as a component of a liquid crystal composition. “Liquid crystal compound,” liquid crystal composition,” and “liquid crystal display device” may be occasionally abbreviated as “compound,” “composition,” and “device,” respectively. “Liquid crystal display device” is a generic term for a liquid crystal display panel and a liquid crystal display module. “Clearing point” is a phase transition temperature between the liquid crystal phase and an isotropic phase in the liquid crystal compound. “Minimum temperature of the liquid crystal phase” is a phase transition temperature between a solid and the liquid crystal phase (smectic phase, nematic phase or the like) in the liquid crystal compound. “Maximum temperature of the nematic phase” is a phase transition temperature between the nematic phase and the isotropic phase in the liquid crystal composition, and may be occasionally abbreviated as “maximum temperature.” A minimum temperature of the nematic phase may be occasionally abbreviated as “minimum temperature.” A compound represented by formula (1) may be occasionally abbreviated as “compound (1).” The abbreviation may be occasionally applied to a compound represented by formula (2) or the like. In formulas (1) to (14), a symbol such as A1, B1 and C1 surrounded by a hexagonal shape corresponds to ring A1, ring B1, ring C1 or the like, respectively. A plurality of R2 are described in identical formulas or different formulas. In the compounds, two groups represented by two of arbitrary R2 may be identical or different. A same rule also applies to a symbol such as ring A1 and Z1. An amount of compound expressed in terms of percentage is expressed in terms of weight percent (% by weight) based on the total weight of the composition.


An expression “at least one of “A” may be replaced by “B”” means that, when the number of “A” is one, a position of “A” is arbitrary, and also when the number of “A” is two or more, positions thereof can be selected without limitation. An expression “at least one of A may be replaced by B, C or D” includes a case where arbitrary A is replaced by B, a case where arbitrary A is replaced by C, a case where arbitrary A is replaced by D, and also a case where a plurality of A are replaced by at least two of B, C and D. For example, alkyl in which at least one of —CH2— may be replaced by —O— or —CH═CH—” includes alkyl, alkenyl, alkoxy, alkoxyalkyl, alkoxyalkenyl and alkenyloxyalkyl. In addition, replacement of two successive —CH2— by —O— to form —O—O— or the like is not preferred. In alkyl or the like, replacement of —CH2— in a methyl part (—CH2—H) by —O— to form —O—H is not preferred, either.


Then, 2-fluoro-1,4-phenylene means inclusion of two divalent groups described below. In the chemical formula, fluorine may be bonded in a left (L) or right (R) direction. A same rule also applies to an asymmetric divalent ring such as tetrahydropyran-2,5-diyl.




embedded image


The invention includes the content as described in item 1 to item 16 below.


Item 1. A compound represented by formula (1):




embedded image



wherein, in the formula,


R1 is alkyl having 1 to 20 carbons, and in the alkyl, at least one of —CH2— may be replaced by —O—, and at least one of —(CH2)2— may be replaced by —CH═CH—;


ring A1, ring A2 and ring A3 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene in which hydrogen may be replaced by halogen, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl;


Z1 and Z3 are independently a single bond, —(CH2)2—, —CH═CH—, —CF2O—, —CH2O—, —CF═CF—, —(CH2)2CF2O—, —CH═CHCF2O—, —CF2—O—(CH2)2—, —CF2OCH═CH—, —CH═CH—(CH2)2— or —(CH2)2—CH═CH—;


Z2 is —CF2O—;


L1, L2 and L3 are independently hydrogen or halogen; and


m and n are independently 0, 1, 2 or 3, and a sum of m and n is 0, 1, 2 or 3, and when m or n is 2 or 3, a plurality of ring A1 or ring A3 may be identical or different, and a plurality of Z1 or Z3 may be identical or different.


However, when ring A2 is 1,4-phenylene, or 1,4-phenylene in which one of hydrogen is replaced by halogen, m is 1 and n is 0, ring A1 is 1,4-phenylene in which hydrogen may be replaced by halogen, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl; and when a sum of m and n is 0, ring A2 is 1,4-cyclohexylene, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl.


Item 2. The compound according to item 1, wherein R1 is alkyl having 1 to 20 carbons or alkenyl having 2 to 20 carbons;


ring A1, ring A2 and ring A3 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl;


Z1 and Z3 are independently a single bond, —CH═CH— or —CF2O—; and


L1, L2 and L3 are independently hydrogen or fluorine.


Item 3. The compound according to item 1 or 2, wherein m is 1 or 2.


Item 4. The compound according to any one of items 1 to 3, wherein ring A2 is 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene or 2,6-difluoro-1,4-phenylene.


Item 5. The compound according to any one of items 1 to 4, wherein Z1 is a single bond.


Item 6. The compound according to any one of items 1 to 5, wherein n is 0.


Item 7. A compound represented by any one of formula (1-1) to formula (1-5):




embedded image



wherein, in the formulas, R2 is alkyl having 1 to 5 carbons, alkenyl having 2 to 6 carbons or alkoxy having 1 to 5 carbons; and L1′, L2′, L3′, L4, L5, L6 and L7 are independently hydrogen or fluorine.


Item 8. A compound represented by any one of formula (1-6) to formulas (1-11):




embedded image



wherein, in the formulas, R2 is alkyl having 1 to 5 carbons, alkenyl having 2 to 6 carbons or alkoxy having 1 to 5 carbons; and L1′, L2′, L3′, L4, L5, L6, L7, L8 and L9 are independently hydrogen or fluorine.


Item 9. A liquid crystal composition containing at least one of compound according to any one of items 1 to 8:


Item 10. The liquid crystal composition according to item 9, further containing at least one of compound selected from the group of compounds represented by formulas (2) to (4):




embedded image



wherein, in the formulas,


R3 is alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of hydrogen may be replaced by fluorine, and at least one of —CH2— may be replaced by —O—;


X1 is fluorine, chlorine, —OCF3, —OCF2H, —CF3, —CHF2, —CH2F, —CF═CF2, —OCF2CHF2 or —OCF2CHFCF3;


ring B1, ring B2 and ring B3 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl;


Z4 and Z5 are independently a single bond, —(CH2)2—, —CH═CH—, —C≡C—, —COO—, —CF2O—, —OCF2—, —CH2O— or —(CH2)4—, and Z4 and Z5 are not simultaneously —CF2O— or —OCF2—; and


L10 and L11 are independently hydrogen or fluorine.


Item 11. The liquid crystal composition according to item 9, further containing at least one of compound selected from the group of compounds represented by formula (5):




embedded image



wherein, in the formula,


R4 is alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of hydrogen may be replaced by fluorine, and at least one of —CH2— may be replaced by —O—;


X2 is —C≡N or —C≡C—C≡N;


Ring C1, ring C2 and ring C3 are independently 1,4-cyclohexylene, 1,4-phenylene in which at least one of hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl or pyrimidine-2,5-diyl;


Z6 is a single bond, —(CH2)2—, —C≡C—, —COO—, —CF2O—, —OCF2— or —CH2O—;


L12 and L13 are independently hydrogen or fluorine; and


p is 0, 1 or 2, q is 0 or 1, and a sum of p and q is 0, 1, 2 or 3.


Item 12. The liquid crystal composition according to item 9, further containing at least one of compound selected from the group of compounds represented by formulas (6) to (11):




embedded image



wherein, in the formulas,


R5 and R6 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of hydrogen may be replaced by fluorine, and at least one of —CH2— may be replaced by —O—;


ring D1, ring D2, ring D3 and ring D4 are independently 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene in which at least one of hydrogen may be replaced by fluorine, tetrahydropyran-2,5-diyl or decahydro-2,6-naphthalene;


Z7, Z8, Z9 and Z10 are independently a single bond, —(CH2)2—, —COO—, —CH2O—, —OCF2— or —OCF2(CH2)2—;


L14 and L15 are independently fluorine or chlorine; and j, k, l, s, t and u are independently 0 or 1, and a sum of k, l, s and t is 1 or 2.


Item 13. The liquid crystal composition according to any one of items 9 to 12, further containing at least one of compound selected from the group of compounds represented by formulas (12) to (14):




embedded image



wherein, in the formulas,


R7 and R8 are independently alkyl having 1 to 10 carbons or alkenyl having 2 to 10 carbons, and in the alkyl and the alkenyl, at least one of hydrogen may be replaced by fluorine and at least one of —CH2— may be replaced by —O—;


ring E1, ring E2 and ring E3 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene or pyrimidine-2,5-diyl; and Z11 and Z12 are independently a single bond, —(CH2)2—, —CH═CH—, —C≡C— or —COO—.


Item 14. The liquid crystal composition according to item 9, further containing at least one of optically active compound.


Item 15. The liquid crystal composition according to item 9, further containing at least one of antioxidant and/or ultraviolet light absorber.


Item 16. A liquid crystal display device including the liquid crystal composition according to any one of items 9 to 15.


The compound, the liquid crystal composition and the liquid crystal display device according to the invention will be explained in the order.


1-1. Compound (1)


The compound of the invention has a 2,2-difluorovinyloxy group and —CF2O— in a structure, and thus produces an effect such as a small viscosity, a large dielectric anisotropy and a high clearing point.


Compound (1) and preferred examples of compound (1) according to the invention will be explained. Preferred examples of a terminal group, a ring structure, a bonding group and a substituent in compound (1) are also applied to the formula below of compound (1).




embedded image



wherein, in formula (1), R1 is alkyl having 1 to 20 carbons, and in the alkyl, at least one of —CH2— may be replaced by —O—, and at least one of —(CH2)2— may be replaced by —CH═CH—.


The groups have a straight chain, and do not include a cyclic group such as cyclohexyl. When the groups have the straight chain, a temperature range of a liquid crystal phase of a compound is wide and viscosity is small.


Examples of the alkyl include ordinarily straight-chain alkyl having 1 to 20 carbons, preferably, straight-chain alkyl having 1 to 15 carbons, further preferably, straight-chain alkyl having 1 to 5 carbons. Specific examples include —CH3, —C2H5, —C3H7, —C4H9, —C5H11, —C6H13, —C7H15, —C8H17, —C9H19, —C10H21, —C11H23, —C12H25, —C13H27, —C14H29 and —C15H31.


A specific example of groups in which, in the alkyl, at least one of —(CH2)2— is replaced by —CH═CH— includes alkenyl. A preferred configuration of —CH═CH— in the alkenyl depends on a position of a double bond. A trans configuration is preferred in alkenyl having the double bond in an odd-numbered position, such as —CH═CHCH3, —CH═CHC2H5, —CH═CHC3H7, —CH═CHC4H9, —C2H4—CH═CHCH3 and —C2H4—CH═CHC2H5. A cis configuration is preferred in alkenyl having the double bond in an even-numbered position, such as —CH2CH═CHCH3, —CH2CH═CHC2H5 and —CH2CH═CHC3H7. An alkenyl compound having a preferred configuration has a high clearing point or a wide temperature range of the liquid crystal phase. A detailed description is found in Mol. Cryst. Liq. Cryst., 1985, 131, 109 and Mol. Cryst. Liq. Cryst., 1985, 131, 327.


Examples of the alkenyl include ordinarily alkenyl having 2 to 20 carbons, preferably, alkenyl having 2 to 15 carbons, further preferably, alkenyl having 2 to 6 carbons. Specific examples include —CH═CH2, —CH═CHCH3, —CH2CH═CH2, —CH═CHC2H5, —CH2CH═CHCH3, —(CH2)2—CH═CH2, —CH═CHC3H7, —CH2CH═CHC2H5, —(CH2)2—CH═CHCH3 and —(CH2)3—CH═CH2.


Specific examples of groups in which, in the alkyl, at least one of —CH2— is replaced by —O— include alkoxy and alkoxyalkyl. Examples of the alkoxy include ordinarily alkoxy having 1 to 20 carbons, preferably, alkoxy having 1 to 15 carbons, further preferably, alkoxy having 1 to 5 carbons. Specific examples include —OCH3, —OC2H5, —OC3H7, —OC4H9, —OC6H13, —OC7H15, —OC8H17, —OC9H19, —OC10H21, —OC11H23, —OC12H25, —OC13H27, —OC14H29 and —OC15H31. Specific examples of the alkoxyalkyl include groups formed by introducing one oxygen atom into the alkyl, and include ordinarily alkoxyalkyl having 2 to 20 carbons, preferably, alkoxyalkyl having 2 to 15 carbons, further preferably, alkoxyalkyl having 2 to 6 carbons. Specific examples include —CH2OCH3, —CH2OC2H5, —CH2OC3H7 and —(CH2)2OC2H5.


Alkyl represented by R1 also includes groups in which at least one of —(CH2)2— in the alkyl is replaced by] —CH═CH—, and at least one of —CH2— in the alkyl is replaced by —O—. Specific examples of such groups include —OCH2CH═CH2 and —OCH2CH═CHCH3.


Preferred examples of R1 include alkyl having 1 to 15 carbons and alkenyl having 2 to 15 carbons. Further preferred example of R1 include —CH3, —C2H5, —C3H7, —C4H9, —C5H11, —C6H13, —C7H15, —C8H17, —C9H19, —C10H21, —C11H23, —C12H25, —C13H27, —C14H29, —C15H31, —CH═CH2, —CH═CHCH3, —CH2CH═CH2, —CH═CHC2H5, —CH2CH═CHCH3, —(CH2)2—CH═CH2, —CH═CHC3H7, —CH2CH═CHC2H5, —(CH2)2—CH═CHCH3 and —(CH2)3—CH═CH2. Particularly preferred examples include —CH3, —C2H5, —C3H7, —C4H9, —C5H11, —CH═CH2 and —(CH2)2—CH═CH2.


In formula (1), ring A1 is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene in which hydrogen may be replaced by halogen, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl.


Preferred examples of ring A1 include 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl.


In formula (1), ring A2 is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene in which hydrogen may be replaced by halogen, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl.


Preferred examples of ring A2 include 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene or 2,6-difluoro-1,4-phenylene.


Most preferred examples of ring A2 include 1,4-cyclohexylene or 2,6-difluoro-1,4-phenylene.


In formula (1), ring A3 is 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene in which hydrogen may be replaced by halogen, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl.


Preferred examples of ring A3 include 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene or 2,6-difluoro-1,4-phenylene.


Most preferred examples of ring A3 include 1,4-cyclohexylene or 1,4-phenylene.


Preferred examples of 2-fluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl in ring A1, ring A2 and ring A3 include groups (R-1) to (R-4).




embedded image



wherein, in formula (1), Z1 is a single bond, —(CH2)2—, —CH═CH—, —CF2O—, —CH2O—, —CF═CF—, —(CH2)2CF2O—, —CH═CHCF2O—, —CF2—O—(CH2)2—, —CF2OCH═CH—, —CH═CH—(CH2)2— or —(CH2)2—CH═CH—.


Preferred examples of Z1 include a single bond, —(CH2)2—, —CH═CH—, —CF2O— or —CH2O—.


Most preferred examples of Z1 include a single bond or —CF2O—.


In formula (1), Z2 is —CF2O—.


In formula (1), Z3 is a single bond, —(CH2)2—, —CH═CH—, —CF2O—, —CH2O—, —CF═CF—, —(CH2)2CF2O—, —CH═CHCF2O—; —CF2O(CH2)2—, —CF2OCH═CH—, —CH═CH—(CH2)2— or —(CH2)2—CH═CH—.


Preferred examples of Z3 include a single bond, —(CH2)2—, —CH═CH—, —CF2O— or —CH2O—.


Most preferred examples of Z3 include a single bond or —CF2O—.


In formula (1), L1, L2 and L3 are independently hydrogen or halogen. Preferred L1, L2 and L3 are independently hydrogen, fluorine or chlorine, and further preferred L1, L2 and L3 are independently hydrogen or fluorine.


In formula (1), m and n are independently 0, 1, 2 or 3, and when m or n is 2, two of ring A1 or ring A3 may be identical or different, and two of Z1 or Z3 may be identical or different.


Moreover, a sum of m and n is ordinarily 0, 1, 2 or 3, preferably, 1 or 2.


1-2. Physical Properties of Compound (1)


When kinds of R1, ring A1, ring A2, ring A3, Z1, Z2, Z3, L1, L2, m and n are suitably combined in compound (1), physical properties such as a clearing point, optical anisotropy and dielectric anisotropy can be arbitrarily adjusted. Compound (1) may also contain isotopes such as 2H (deuterium) and 13C in an amount higher than an amount of natural abundance because no significant difference is present in the physical properties of the compound. Main effects of kinds of R1 or the like on the physical properties of compound (1) will be explained below.


When left-terminal group R1 is straight-chain alkyl, the temperature range of the liquid crystal phase is wide, and the viscosity is small, and compound (1) is useful as a component of the composition. When R1 is alkenyl, a preferred configuration depends on a position of a double bond. An alkenyl compound having the preferred configuration has a high maximum temperature or a wide temperature range of the liquid crystal phase.


When all of ring A1, ring A2 and ring A3 are 1,4-cyclohexylene, the clearing point is high and the viscosity is small. When at least one of ring A1, ring A2 and ring A3 is 1,4-phenylene or 1,4-phenylene in which at least one of hydrogen is replaced by halogen (fluorine or chlorine, for example), the optical anisotropy is relatively large and an orientational order parameter is relatively large. When at least one of ring A1, ring A2 and ring A3 is 2,6-difluoro-1,4-phenylene, the dielectric anisotropy is positively large.


When the bonding group is a single bond, —(CH2)2—, —CH═CH—, —CF2O—, —CH2O—, —CF═CF—, —(CH2)2—CF2O— or —OCF2— (CH2)2—, the viscosity is small. When the bonding group is a single bond, —(CH2)2—, —CF2O— or —CH═CH—, the viscosity is smaller. When the bonding group is —CH═CH—, the temperature range of the liquid crystal phase is wide, and an elastic constant (K) is large, and when the bonding group is a single bond or —(CH2)2—, chemical stability is high.


When both L1 and L2 are fluorine and L3 is hydrogen, the chemical stability is high, the temperature range of the liquid crystal phase is wide, and the dielectric anisotropy is large.


When a sum of n and m is 0, the viscosity is small. When a sum of n and m is 3, the maximum temperature is high.


As described above, when kinds of the ring structure, the terminal group, the bonding group or the like are suitably selected, a compound having objective physical properties can be obtained. Accordingly, compound (1) is useful as a component of the liquid crystal composition to be used for a liquid crystal display device having a mode such as a PC, TN, STN, ECB, OCB, IPS or VA mode.


1-3. Preferred Compound


As described above, preferred examples of compound (1) include compounds (1-1) to (1-5) (when a sum of n and m is 2), and compounds (1-6) to (1-11) (when a sum of n and m is 3).




embedded image



wherein, in the formulas, R2 is alkyl having 1 to 5 carbons, alkenyl having 2 to 6 carbons or alkoxy having 1 to 5 carbons; and L1′, L2′, L3′, L4, L5, L6 and L7 are independently hydrogen or fluorine.




embedded image


embedded image



wherein, in the formulas, R2 is alkyl having 1 to 5 carbons, alkenyl having 2 to 6 carbons or alkoxy having 1 to 5 carbons; and L1′, L2′, L3′, L4, L5, L6, L7, L8 and L9 are independently hydrogen or fluorine.


1-4. Synthesis of Compound (1)


A process for synthesizing compound (1) will be explained. Compound (1) can be prepared by suitably combining methods in synthetic organic chemistry. Methods for introducing an objective terminal group, ring and bonding group into a starting material are described in books such as “Organic Syntheses” (John Wiley & Sons, Inc.), “Organic Reactions” (John Wiley & Sons, Inc.), “Comprehensive Organic Synthesis” (Pergamon Press) and “New Experimental Chemistry Course (Shin Jikken Kagaku Koza in Japanese)” (Maruzen Co., Ltd.).


1-4-1. Formation of a Bonding Group

An example of a method for forming a bonding group in compound (1) is as described in a scheme below. In the scheme, MSG1 (or MSG2) is a monovalent organic group having at least one ring. A plurality of monovalent organic groups represented by MSG1 (or MSG2) may be identical or different. Compounds (1A) to (1i) correspond to compound (1).




embedded image


embedded image



(I) Formation of a Single Bond (Synthesis of Compound (1A))


Compound (1A) is prepared by allowing arylboronic acid (21) to react, in the presence of a catalyst such as tetrakis(triphenylphosphine)palladium in an aqueous solution of carbonate, with compound (22) to be prepared according to a publicly known method. Compound (1A) is also prepared by allowing compound (23) to be prepared according to a publicly known method to react with n-butyllithium, and subsequently with zinc chloride, and further with compound (22) in the presence of a catalyst such as dichlorobis(triphenylphosphine)palladium.


(II) Formation of —CF2O— (Synthesis of Compound (1B))


Carboxylic acid (24) is obtained by allowing compound (23) to react with n-butyllithium, and subsequently with carbon dioxide. Compound (26) having —COO— is prepared by dehydrating, in the presence of 1,3-dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP), compound (24) and phenol (25) to be prepared according to a publicly known method. Compound (27) is obtained by treating compound (26) with a thiation reagent such as Lawesson's reagent. Compound (1B) having —CF2O— is prepared by fluorinating compound (27) with a hydrogen fluoride-pyridine complex and N-bromosuccinimide (NBS). See M. Kuroboshi et al., Chem. Lett., 1992, 827. Compound (1B) is also prepared by fluorinating compound (27) with (diethylamino)sulfur trifluoride (DAST). See W. H. Bunnelle et al., J. Org. Chem. 1990, 55, 768.


(III) Formation of —CH═CH— (Synthesis of Compound (1C))


Aldehyde (28) is obtained by treating compound (22) with n-butyllithium, and then allowing the treated compound to react with formamide such as N,N-dimethylformamide (DMF). Compound (1C) is prepared by allowing aldehyde (28) to react with phosphorus ylide generated by treating phosphonium salt (29) to be prepared according to a known method with a base such as potassium tert-butoxide. Because a cis isomer is formed depending on reaction conditions, the cis isomer is isomerized into a trans isomer according to a known method, when necessary.


(IV) Formation of —(CH2)2— (Synthesis of Compound (1D))


Compound (1D) is prepared by hydrogenating compound (1C) in the presence of a catalyst such as palladium on carbon.


(V) Formation of —CH2O— (Synthesis of Compound (1E))


Compound (30) is obtained by reducing compound (28) with a reducing agent such as sodium borohydride. Compound (31) is obtained by halogenating compound (28) with hydrobromic acid or the like. Compound (1E) is prepared by allowing compound (31) to react with compound (25) in the presence of potassium carbonate or the like.


(VI) Formation of —CF═CF— (Synthesis of Compound (1F))


Compound (32) is obtained by treating compound (23) with n-butyllithium, and then allowing the treated compound to react with tetrafluoroethylene. Compound (1F) is prepared by treating compound (32) with n-butyllithium, and then allowing the treated compound to react with compound (3).


(VII) Formation of —CH═CHCF2O— (Synthesis of Compound (1G))


Aldehyde (33) is obtained by allowing compound (23) to react with n-butyllithium, and subsequently with formamide such as N,N-dimethylformamide (DMF). Carboxylic acid (34) is prepared by allowing compound (33) to react with PPh3=CHCO2H. Compound (1G) is prepared by allowing compound (34) to be subjected to a dehydrating condensation reaction, fluorination or the like with phenol (25) in a manner similar to preparation of —CF2O—.


(VIII) Formation of —(CH2)2CF2O— (Synthesis of Compound (1H))


Compound (37) is obtained by hydrogenating compound (35) in the presence of a catalyst such as palladium on carbon. Compound (38) is obtained by treating compound (37) with a thiation reagent such as a Lawesson's reagent. Compound (1H) is prepared by fluorinating compound (38) with a hydrogen fluoride-pyridine complex and N-bromosuccinimide (NBS).


(IX) Formation of —CH═CH—(CH2)2— (Synthesis of Compound (1i))


Compound (1i) is prepared by allowing aldehyde (28) to react with phosphorus ylide generated by treating phosphonium salt (39) to be prepared according to a known method with a base such as potassium tert-butoxide.


1-4-2. Formation of Rings A1, A2 and A3

With regard to a ring such as 1,4-cyclohexylene, 1,4-cyclohexenylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,3-difluoro-1,4-phenylene, 2,5-difluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, 2,3,5,6-tetrafluoro-1,4-phenylene, tetrahydropyran-2,5-diyl and 1,3-dioxane-2,5-diyl, a starting material is commercially available or a synthetic process is well known.


1-4-3. Synthesis Example

An example of a method for preparing compound (1) is as described below. Phenol (42) is obtained by allowing compound (41) that can be prepared by a known method to react with n-butyllithium, and subsequently with trimethoxy borane, and further with a hydrogen peroxide aqueous solution. Compound (43) is obtained by allowing compound (42) to react with 1-methyl-4-(2,2,2-trifluoroethoxy)benzene and potassium carbonate. Compound (1) is prepared by allowing compound (43) to react with lithium diisopropylamide (LDA).




embedded image


In the compounds, R1, ring A1, ring A2, ring A3, Z1, Z2, Z3, L1, L2, m and n are defined in a manner identical with the definitions described above.


2-1. Composition (1)


Liquid crystal composition (1) of the invention will be explained. Composition (1) contains at least one of compound (1) as component A. Composition (1) may contain two or more compounds (1). A component of the liquid crystal compound may include only compound (1). In order to develop excellent physical properties, composition (1) preferably contains at least one of compound (1) in the range of approximately 1 to approximately 99% by weight. A further preferred ratio is in the range of approximately 5 to approximately 60% by weight. Composition (1) may also contain compound (1) and various kinds of liquid crystal compounds that are not described herein.


A preferred composition contains a compound selected from components B, C, D and E shown below. When preparing composition (1), a component can also be selected, for example, in consideration of the dielectric anisotropy of compound (1). A composition prepared by suitably selecting components has a high maximum temperature of the nematic phase, a low minimum temperature of the nematic phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy and a suitable elastic constant.


Component B includes compounds (2) to (4). Component C includes compound (5). Component D includes compounds (6) to (11). Component E includes compounds (12) to (14). The components will be explained in the order.


Component B includes a compound having a halogen-containing group or a fluorine-containing group at a right terminal. Preferred examples of component B include compounds (2-1) to (2-16), compounds (3-1) to (3-112) and compounds (4-1) to (4-54). In addition, in formulas (3) and (4), a case where both Z4 and Z5 are —CF2O— and/or —OCF2— is excluded. The exclusion means that component B does not contain a compound in which both Z4 and Z5 are —CF2O—, a compound in which both Z4 and Z5 are —OCF2—, and a compound in which one of Z4 and Z5 is —CF2O— and the other is —OCF2—.




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


In the compounds (component B), R3 and X1 are defined in a manner identical with the definitions described above.


Component B has a positive dielectric anisotropy and has a superb stability to heat, light and so forth, and therefore is used when preparing a composition for the TFT mode or the PSA mode. Content of component B is suitably in the range of approximately 1 to approximately 99% by weight, preferably, in the range of approximately 10 to approximately 97% by weight, still further preferably, in the range of approximately 40 to approximately 95% by weight, based on the total weight of the composition. When compounds (12) to (14) are further added to the composition, the viscosity can be adjusted.


Component C includes compound (5) in which a right-terminal group is —C≡N or —C≡C—C≡N. Preferred examples of component C include compounds (5-1) to (5-64).




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


In the compounds (component C), R4 and X2 are defined in a manner identical with the definitions described above.


Component C has a very large positive value of dielectric anisotropy, and therefore is mainly used when preparing a composition for the STN mode, the TN mode or the PSA mode. When component C is added to the composition, the dielectric anisotropy of the compound can be increased. Compound C is effective in extending the temperature range of the liquid crystal phase, adjusting the viscosity or adjusting the optical anisotropy. Component C is also useful for adjusting a voltage-transmittance curve of the device.


When preparing a composition for the STN mode or the TN mode, content of component C is suitably in the range of approximately 1 to approximately 99% by weight, preferably, in the range of approximately 10 to approximately 97% by weight, further preferably, in the range of approximately 40 to approximately 95% by weight, based on the total weight of the composition. When component E is added to the composition, the temperature range of the liquid crystal phase, the viscosity, the optical anisotropy, the dielectric anisotropy or the like can be adjusted.


Component D includes compounds (6) to (11). The compounds have a benzene ring in which lateral positions are replaced by two halogen atoms, such as 2,3-difluoro-1,4-phenylene. Preferred examples of component D include compounds (6-1) to (6-6), compounds (7-1) to (7-15), compound (8-1), compounds (9-1) to (9-3), compounds (10-1) to (10-11) and compounds (11-1) to (11-10).




embedded image


embedded image


embedded image


embedded image


embedded image


embedded image


In the compounds (component D), R5 and R6 are defined in a manner identical with the definitions described above.


Component D includes a compound having a negative dielectric anisotropy. Component D is mainly used when preparing a composition for the VA mode or the PSA modes. If content of component D is increased, the dielectric anisotropy of the composition increases, but the viscosity also increases. Thus, the content is preferably decreased, as long as a required value of dielectric anisotropy is satisfied. Accordingly, in consideration of approximately 5 of an absolute value of dielectric anisotropy, the content is preferably in the range of approximately 40% by weight or more based on the total weight of the composition in order to allow sufficient voltage driving.


Among types of compound D, compound (6) is a bicyclic compound, and therefore effective mainly in adjusting the viscosity, the optical anisotropy or the dielectric anisotropy. Compound (7) and compound (8) each are a tricyclic compound, and therefore effective in increasing the maximum temperature, the optical anisotropy or the dielectric anisotropy. Compounds (9) to (11) each are effective in increasing the dielectric anisotropy.


When preparing a composition for the VA mode or the PSA mode, the content of component D is preferably in the range of approximately 40% by weight or more, further preferably, in the range of approximately 50 to approximately 95% by weight, based on the total weight of the composition. When component D is added to the composition, the elastic constant of the composition can be adjusted, and the voltage-transmittance curve of the device can be adjusted. When component D is added to a composition having a positive dielectric anisotropy, the content of component D is preferably in the range of approximately 30% by weight or less based on the total weight of the composition.


Component E includes a compound in which two terminal groups are alkyl or the like. Preferred examples of component E include compounds (12-1) to (12-11), compounds (13-1) to (13-19) and compounds (14-1) to (14-6).




embedded image


embedded image


embedded image


embedded image


In the compounds (component E), R7 and R8 are defined in a manner identical with the definitions described above.


Component E has a small absolute value of dielectric anisotropy, and therefore is close to neutrality. Compound (12) is effective mainly in adjusting the viscosity or the optical anisotropy. Compound (13) and compound (14) are effective in extending the temperature range of the nematic phase by increasing the maximum temperature, or effective in adjusting the optical anisotropy.


If content of component E is increased, the viscosity of the composition decreases, but the dielectric anisotropy decreases. Thus, the content is preferably increased, as long as a required value for the dielectric anisotropy is satisfied. Accordingly, when preparing a composition for the VA mode or the PSA mode, the content of component E is preferably in the range of approximately 30% by weight or more, and further preferably, in the range of approximately 40% by weight or more, based on the total weight of the composition.


2-2. Preparation of Composition (1) and Additive


Composition (1) is prepared according to a method for dissolving required components at a high temperature, or the like. According to an application, an additive may be added to the composition. Examples of the additives include an optically active compound, a polymerizable compound, a polymerization initiator, an antioxidant and an ultraviolet light absorber. Such additives are well known to those skilled in the art, and are described in literatures.


Composition (1) may further contain at least one optically active compound. As the optically active compound, a publicly known chiral dopant can be added. The chiral dopant is effective in inducing a helical structure of liquid crystals to give a required twist angle, and preventing an inverted twist. Preferred examples of the chiral dopants include optically active compounds (Op-1) to (Op-13) below.




embedded image


embedded image


A helical pitch of composition (1) is adjusted by adding such an optically active compound. The helical pitch is preferably adjusted to the range of approximately 40 to approximately 200 micrometers for a composition for the TFT mode and the TN mode. The helical pitch is preferably adjusted to the range of approximately 6 to approximately 20 micrometers for a composition for the STN mode. The helical pitch is preferably adjusted to the range of approximately 1.5 to approximately 4 micrometers for a composition for the BTN mode. Two or more kinds of optically active compounds may be added for the purpose of adjusting temperature dependence of the helical pitch.


Composition (1) can also be used for the PSA mode by adding the polymerizable compound. Examples of the polymerizable compounds include an acrylate, a methacrylate, a vinyl compound, a vinyloxy compound, a propenyl ether, an epoxy compound (oxirane, oxetane) and a vinyl ketone. The polymerizable compound is preferably polymerized by irradiation with ultraviolet light in the presence of a suitable polymerization initiator such as a photopolymerization initiator. Suitable conditions for polymerization, suitable types and suitable amounts of the polymerization initiator are known to those skilled in the art and described in literatures.


The antioxidant is effective in maintaining a large voltage holding ratio. Preferred examples of the antioxidants include 2,6-di-tert-butyl-4-alkyl phenol. The ultraviolet light absorber is effective in preventing a decrease in the maximum temperature. Preferred examples of the ultraviolet light absorbers include a benzophenone derivative, a benzoate derivative and a triazole derivative. Alight stabilizer such as an amine having steric hindrance is also preferred.


If a dichroic dye of a merocyanine type, a styryl type, an azo type, an azomethine type, an azoxy type, a quinophthalone type, an anthraquinone type, a tetrazine type or the like is added to the composition, composition (1) can also be used for a guest-host (GH) mode.


3. Liquid Crystal Display Device


Composition (1) can be used for a liquid crystal display device that has the operating mode such as the PC mode, the TN mode, the STN mode, the OCB mode and the PSA mode, and is driven according to an active matrix (AM) mode. Composition (1) can also be used for a liquid crystal display device that has the operating mode such as the PC mode, the TN mode, the STN mode, the OCB mode, the VA mode and the IPS mode, and is driven according to a passive matrix (PM) mode. The devices according to the AM mode and the PM mode can also be applied to any type of a reflective type, a transmissive type and a transflective type.


Composition (1) can also be used for a nematic curvilinear aligned phase (NCAP) device prepared by microencapsulating nematic liquid crystals, a polymer dispersed liquid crystal display device (PDLCD) and a polymer network liquid crystal display device (PNLCD) as prepared by forming a three-dimensional network polymer in the liquid crystals.


It will be apparent to those skilled in the art that various modifications and variations can be made in the invention and specific examples provided herein without departing from the spirit or scope of the invention. Thus, it is intended that the invention covers the modifications and variations of this invention that come within the scope of any claims and their equivalents.


The following examples are for illustrative purposes only and are not intended, nor should they be interpreted to, limit the scope of the invention.


EXAMPLES

Hereinafter, the invention will be explained in more detail by way of Examples, but the invention is not limited by the Examples.


1-1. Examples of Compound (1)

Compound (1) was prepared according to procedures as described below. A compound prepared was identified by a method such as an NMR analysis. Physical properties of the compound were measured by methods as described below.


NMR Analysis


As a measuring apparatus, DRX-500 (made by Bruker BioSpin Corporation) was used. In measurement of 1H-NMR, a sample was dissolved into a deuterated solvent such as CDCl3, and measurement was carried out under the conditions of room temperature, 500 MHz and 16 times of accumulation. Tetramethylsilane was used as a reference material. In measurement of 19F-NMR, CFCl3 was used as a reference material, and measurement was carried out under the conditions of 24 times of accumulation. In the explanation of nuclear magnetic resonance spectra, s, d, t, q, quin, sex, m and br stand for a singlet, a doublet, a triplet, a quartet, a quintet, a sextet, a multiplet and broad, respectively.


Measurement Sample


When measuring a phase structure and a transition temperature, a liquid crystal compound per se was used as a sample. When measuring physical properties such as a maximum temperature of a nematic phase, viscosity, optical anisotropy and dielectric anisotropy, a composition prepared by mixing a compound with a base liquid crystal was used as a sample.


When using the sample in which the compound is mixed with the base liquid crystal, measurement was carried out according to the methods described below. A sample was prepared by mixing 15% by weight of compound with 85% by weight of base liquid crystal. Extrapolated values were calculated from measured values of the sample, according to an extrapolation method represented by an equation described below, and the values were described.

(Extrapolated value)={100×(measured value of a sample)−(% by weight of base liquid crystal)×(measured value of the base liquid crystal)}/(% by weight of compound).


When a crystal (or a smectic phase) precipitated at 25° C. even at the ratio of the compound to the base liquid crystal, a ratio of the compound to the base liquid crystal was changed in the order of (10% by weight:90% by weight), (5% by weight:95% by weight) and (1% by weight:99% by weight), and physical properties of a sample were measured at a ratio at which no crystal (or no smectic phase) precipitated at 25° C. In addition, unless otherwise noted, the ratio of the compound to the base liquid crystal is 15% by weight:85% by weight.


As the base liquid crystal, base liquid crystal (i) as described below was used. Ratios of components in base liquid crystal (i) are expressed in terms of weight percent.




embedded image



Measuring Method


Physical properties were measured according to the methods described below. Most of the methods are applied as described in the Standard of Japan Electronics and Information Technology Industries Association (hereinafter, abbreviated as JEITA) as the JEITA standard (JEITA ED-2521A) to be discussed and established in JEITA, or as modified thereon. No TFT was attached to a TN device used for measurement.


(1) Phase Structure


A sample was placed on a hot plate of a melting point apparatus (FP-52 Hot Stage made by Mettler-Toledo International Inc.) equipped with a polarizing microscope, and a state of phase and a change thereof were observed with the polarizing microscope while heating the sample at a rate of 3° C. per minute, and a kind of the phase was specified.


(2) Phase Transition Temperature (° C.)


A sample was heated and then cooled at a rate of 3° C. per minute using a differential scanning calorimeter, DSC-7 System or Diamond DSC System, made by PerkinElmer, Inc. A starting point of an endothermic peak or an exothermic peak caused by a phase change of the sample was determined by extrapolation, and thus a phase transition temperature was determined. Temperature at which a compound transits from a solid to a liquid crystal phase such as a smectic phase and a nematic phase may be occasionally abbreviated as “minimum temperature of the liquid crystal phase.” Temperature at which a compound transits from the liquid crystal phase to a liquid may be occasionally abbreviated as “clearing point.”


The crystal was expressed as C. When kinds of the crystals were further distinguishable, each of the crystals was expressed as C1 or C2. The smectic phase was expressed as S and the nematic phase as N. When smectic A phase, smectic B phase, smectic C phase or smectic F phase was distinguishable among the smectic phases, the phases were expressed as SA, SB, SC or SF, respectively. A liquid (isotropic) was expressed as I. The phase transition temperature was expressed, for example, as “C 50.0N 100.0 I.” The expression represents that a phase transition temperature from the crystal to the nematic phase is 50.0° C., and a phase transition temperature from the nematic phase to the liquid is 100.0° C.


(3) Compatibility at a Low Temperature


Samples were prepared in which a base liquid crystal and a liquid crystal compound were mixed for a ratio of the compound to be 20% by weight, 15% by weight, 10% by weight, 5% by weight, 3% by weight and 1% by weight, and the samples were put in glass vials. The glass vials were kept in freezers at −10° C. or −20° C. for a fixed period of time, and then whether or not a crystal or a smectic phase precipitated was observed.


(4) Maximum Temperature of a Nematic Phase (TNI or NI; ° C.)


A sample was placed on a hot plate of a melting point apparatus equipped with a polarizing microscope, and heated at a rate of 1° C. per minute. Temperature when part of the sample changed from the nematic phase to the isotropic liquid was measured. A maximum temperature of the nematic phase may be occasionally abbreviated as “maximum temperature.” When the sample was a mixture of the compound and the base liquid crystal, the maximum temperature was expressed using a symbol of TNI. When the sample was a mixture of the compound and component B or the like, the maximum temperature was expressed using a symbol of NI.


(5) Minimum Temperature of a Nematic Phase (Tc; ° C.)


Samples each having a nematic phase were kept in freezers at 0° C., −10° C., −20° C., −30° C. and −40° C. for 10 days, and then liquid crystal phases were observed. For example, when a sample maintained the nematic phase at −20° C. and changed to a crystal or a smectic phase at −30° C., Tc was expressed as Tc≦−20° C. A minimum temperature of the nematic phase may be occasionally abbreviated as “minimum temperature.”


(6) Viscosity (Bulk Viscosity; η; Measured at 20° C.; mPa·s)


Viscosity was measured using a cone-plate (E type) rotational viscometer.


(7) Viscosity (Rotational Viscosity; γ1; Measured at 25° C.; mPa·s)


Measurement was carried out according to a method described in M. Imai et al., Molecular Crystals and Liquid Crystals, Vol. 259, 37 (1995). A sample was put in a TN device in which a twist angle was 0 degrees and a distance (cell gap) between two glass substrates was 5 micrometers. Voltage was stepwise applied to the device in the range of 16 V to 19.5 V at an increment of 0.5 V. After a period of 0.2 second with no voltage application, application was repeated under conditions of only one of rectangular waves (rectangular pulse; 0.2 second) and no application (2 seconds). A peak current and a peak time of a transient current generated by the application were measured. A value of rotational viscosity was obtained from the measured values according to calculating equation (8) on page 40 of the paper by Imai et al. A value of dielectric anisotropy necessary for the calculation was determined by using the device used for measuring the rotational viscosity according to the method as described below.


(8) Optical Anisotropy (Refractive Index Anisotropy; Measured at 25° C.; Δn)


Measurement was carried out by means of Abbe refractometer with a polarizing plate mounted on an ocular by using light at a wavelength of 589 nanometers. A surface of a main prism was rubbed in one direction, and then a sample was added dropwise onto the main prism. A refractive index (n∥) was measured when the direction of polarized light was parallel to the direction of rubbing. A refractive index (n⊥) was measured when the direction of polarized light was perpendicular to the direction of rubbing. A value of optical anisotropy (Δn) was calculated from an equation:

Δn=n∥−n⊥.

(9) Dielectric Anisotropy (Δ∈; Measured at 25° C.)


A sample was put in a TN device in which a distance (cell gap) between two glass substrates was 9 micrometers and a twist angle was 80 degrees. Sine waves (10V, 1 kHz) were applied to the device, and after 2 seconds, a dielectric constant (∈∥) in the major axis direction of liquid crystal molecules was measured. Sine waves (0.5 V, 1 kHz) were applied to the device, and after 2 seconds, a dielectric constant (∈⊥) in the minor axis direction of the liquid crystal molecules was measured. A value of dielectric anisotropy was calculated from an equation: Δ∈=∈∥−∈⊥.


(10) Elastic Constant (K; Measured at 25° C.; pN)


HP4284A LCR Meter made by Yokogawa-Hewlett-Packard Co. was used for measurement. A sample was put in a horizontal alignment cell in which a distance (cell gap) between two glass substrates was 20 micrometers. An electric charge from 0 V to 20 V was applied to the cell, and electrostatic capacity and applied voltage were measured. Measured values of the electrostatic capacity (C) and the applied voltage (V) were fitted to equation (2.98) and equation (2.101) on page 75 of “Liquid Crystal Device Handbook” (Ekisho Debaisu Handobukku in Japanese) (The Nikkan Kogyo Shimbun, Ltd.), and values of K11 and K33 were obtained from equation (2.99). Next, K22 was calculated using the previously determined values of K11 and K33 in equation (3.18) on page 171 of the same Handbook. An elastic constant is a mean value of the thus determined K11, K22 and K33.


(11) Threshold Voltage (Vth; Measured at 25° C.; V)


An LCD-5100 luminance meter made by Otsuka Electronics Co., Ltd. was used for measurement. A light source was a halogen lamp. A sample was put in a normally white mode TN device in which a distance (cell gap) between two glass substrates was 0.45/Δn (μm) and a twist angle was 80 degrees. Voltage (32 Hz, rectangular waves) to be applied to the device was stepwise increased from 0 V to 10 V at an increment of 0.02 V. On the occasion, the device was irradiated with light from a direction perpendicular to the device, and the amount of light transmitted through the device was measured. A voltage-transmittance curve was prepared, in which the maximum amount of light corresponds to 100% transmittance and the minimum amount of light corresponds to 0% transmittance. A threshold voltage is a voltage at 90% transmittance.


(12) Voltage Holding Ratio (VHR-1; at 25° C.; %)


A TN device used for measurement had a polyimide alignment film, and a distance (cell gap) between two glass substrates was 5 micrometers. A sample was put in the device, and then the device was sealed with an ultraviolet-curable adhesive. A pulse voltage (60 microseconds at 5 V) was applied to the device and the device was charged. A decaying voltage was measured for 16.7 milliseconds with a high-speed voltmeter, and area A between a voltage curve and a horizontal axis in a unit cycle was determined. Area B is an area without decay. A voltage holding ratio is a percentage of area A to area B.


(13) Voltage Holding Ratio (VHR-2; at 80° C.; %)


A TN device used for measurement had a polyimide alignment film, and a distance (cell gap) between two glass substrates was 5 micrometers. A sample was put in the device, and then the device was sealed with an ultraviolet-curable adhesive. A pulse voltage (60 microseconds at 5 V) was applied to the TN device and the TN device was charged. A decaying voltage was measured for 16.7 milliseconds with a high-speed voltmeter, and area A between a voltage curve and a horizontal axis in a unit cycle was determined. Area B is an area without decay. A voltage holding ratio is a percentage of area A to area B.


Raw Materials


Solmix A-11 (registered trade name) is a mixture of ethanol (85.5%), methanol (13.4%) and isopropanol (1.1%), and obtained from Japan Alcohol Trading Co., Ltd. Tetrahydrofuran may be occasionally abbreviated as THF.


Example 1
Synthesis of Compound (No. 13)



embedded image


Under a nitrogen atmosphere, compound (e-1) (210 g) and THF (1,200 mL) were put into a reaction vessel, and the resultant mixture was cooled at −20° C. Thereto, isopropyl magnesium chloride (20%; THF solution; 350 g) was slowly added dropwise at −20° C., and the resultant mixture was further stirred for 30 minutes. Subsequently, trimethyl borate (70 g) was added at −20° C., the resultant mixture was stirred for 30 minutes, and then returned to room temperature. After reaction completion, the resultant mixture was subjected to post-treatment with a 10% hydrochloric acid aqueous solution. An aqueous layer was extracted with ethyl acetate, combined organic layers were concentrated under reduced pressure, a residue was washed with heptane, and thus compound (e-2) was obtained.


Second Step


Compound (e-2) and methylene chloride (600 mL) were put into a reaction vessel, and then 1,8-diazabicyclo[5.4.0]undeca-7-en (DBU) (6 g) was added thereto, and a hydrogen peroxide aqueous solution (27%; aqueous solution; 100 mL) was slowly added dropwise at 20° C. The resultant mixture was stirred at 30° C. for 30 minutes, and then a reaction mixture was poured into pure water and an aqueous layer was extracted with dichloromethane. Combined organic layers were sequentially washed with an aqueous solution of sodium thiosulfate and pure water. The solution was concentrated under reduced pressure, and thus compound (e-3) (110 g) was obtained. A yield based on compound (e-1) was 66.7%.


Third Step


Under a nitrogen atmosphere, compound (e-3) (100 g), 1-methyl-4-(2,2,2-trifluoroethoxy)benzene (70 g), potassium carbonate (90 g), potassium iodide (3 g) and DMF (500 mL) were put into a reaction vessel, and the resultant mixture was subjected to heating stirring at 120° C. for 4 hours. A reaction mixture was cooled to room temperature, and subjected to post-treatment with a 15% hydrochloric acid aqueous solution. An aqueous layer was extracted with ethyl acetate, and combined organic layers were concentrated under reduced pressure. A residue was purified by recrystallization from ethanol, and thus compound (e-4) (85 g; 70.6%) was obtained.


Fourth Step


Under a nitrogen atmosphere, compound (e-4) (48 g) and THF (240 mL) were put into a reaction vessel, and the resultant mixture was cooled at −75° C. Thereto, LDA (adjusted from diisopropylamine (70 g) and n-butyllithium (385 mL)) was slowly added dropwise at −75° C. Then, a reaction mixture was returned to room temperature, subjected to post-treatment with pure water, and an aqueous layer was extracted with hexane. Combined organic layers were washed with pure water, and the solution was concentrated under reduced pressure. A residue was passed through silica gel chromatography, and then purified by recrystallization, and thus compound (No. 13) (6 g: 13.0%) was obtained.



1H-NMR (δ ppm; CDCl3): 6.80 (d, 2H, J=8.7 Hz), 6.20 (dd, 1H, J=3.2 Hz, 14.5 Hz), 2.05-1.92 (m, 3H), 1.88-1.81 (m, 2H), 1.79-1.67 (m, 4H), 1.38-1.24 (m, 4H), 1.19-1.11 (m, 3H), 1.10-0.92 (m, 6H), 0.90-0.80 (m, 2H), 0.87 (t, 3H, J=7.4 Hz).



19F-NMR (δ ppm; CFCl3): −79.25 (d, 2F, J=8.8 Hz), −96.28-−96.50 (m, 1F), −118.28 (dd, 1F, J=3.2 Hz, 73.1 Hz), −127.39 (dd, 2F, J=2.0 Hz, 8.7 Hz).


Physical properties of compound (No. 13) were as described below.


Attached data were determined in accordance with the methods described above. When measuring a transition temperature, the compound per se was used as a sample. When measuring a maximum temperature (TNI), viscosity (η), optical anisotropy (Δn) and dielectric anisotropy (Δ∈), a mixture of the compound (15% by weight) and base liquid crystal (i) (85% by weight) was used as a sample. From the measured values, extrapolated valued were calculated in accordance with the extrapolation method described above and described.


Transition temperature: C 32.8N 138.9 I. TNI=105.7° C.; η=25.4 mPa·s; Δn=0.0903; Δ∈=17.4.


Example 2
Synthesis of Compound (No. 22)



embedded image


Compound (No. 22) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.73 (d, 2H, J=8.3 Hz), 7.68 (d, 2H, J=8.3 Hz), 7.53 (d, 2H, J=8.1 Hz), 7.28 (d, 2H, J=8.1 Hz), 6.94 (d, 2H, J=9.7 Hz), 6.23 (dd, 1H, J=3.3 Hz, 14.3 Hz), 2.65 (t, 2H, J=7.6 Hz), 1.69 (tq, 2H, J=7.6 Hz, J=7.3 Hz), 0.98 (t, 3H, J=7.3 Hz).



19F-NMR (δ ppm; CFCl3): −66.52 (s, 2F), −96.13-−96.35 (m, 1F), −118.12 (dd, 1F, J=3.2 Hz, 74.2 Hz), −126.89 (d, 2F, J=9.7 Hz).


Physical properties of compound (No. 22) were as described below.


Transition temperature: C 87.7 I. TNI=57.7° C.; η=20.9 mPa·s; Δn=0.157; Δ∈=23.9.


Example 3
Synthesis of Compound (No. 25)



embedded image


Compound (No. 25) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.48 (d, 2H, J=8.0 Hz), 7.29 (d, 2H, J=8.0 Hz), 7.20 (d, 2H, J=11.0 Hz), 6.95 (d, 2H, J=8.6 Hz), 6.23 (dd, 1H, J=3.3 Hz, 14.3 Hz), 2.65 (t, 2H, J=7.7 Hz), 1.68 (tq, 2H, J=7.7 Hz, J=7.4 Hz), 0.97 (t, 3H, J=7.4 Hz).



19F-NMR (δ ppm; CFCl3): −61.94 (t, 2F, J=27.8 Hz), −96.09-−96.30 (m, 1F), −111.10 (dt, 2F, J=11.0 Hz, 27.8 Hz), −118.07 (dd, 1F, J=3.3 Hz, 73.1 Hz), −126.89 (d, 2F, J=8.6 Hz).


Physical properties of compound (No. 25) were as described below.


Transition temperature: C 32.7 I. TNI=15.7° C.; η=30.4 mPa·s; Δn=0.137; Δ∈=32.6.


Example 4
Synthesis of Compound (No. 67)



embedded image


Compound (No. 67) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 6.80 (d, 2H, J=8.7 Hz), 6.20 (dd, 1H, J=3.1 Hz, 14.4 Hz), 4.19 (d, 1H, J=5.1 Hz), 4.08 (dd, 2H, J=4.5 Hz, 11.3 Hz), 3.29 (dd, 2H, J=11.2 Hz, 11.2 Hz), 2.08-1.92 (m, 6H), 1.59-1.49 (m, 1H), 1.39-1.25 (m, 4H), 1.19-1.08 (m, 2H), 1.05-0.98 (m, 2H), 0.90 (t, 3H, J=7.2 Hz).



19F-NMR (δ ppm; CFCl3): −79.21 (d, 2F, J=8.75 Hz), −96.28-−96.50 (m, 1F), −118.28 (dd, 1F, J=3.1 Hz, 74.2 Hz), 127.35 (d, 2F, J=9.8 Hz).


Physical properties of compound (No. 67) were as described below.


Transition temperature: C 45.5 SB 64.5 N 101.9 I. TNI=71.7° C.; η=44.5 mPa·s; Δn=0.0837; Δ∈=29.9.


Example 5
Synthesis of Compound No. 70



embedded image


Compound (No. 70) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.13 (d, 2H, J=10.1 Hz), 6.91 (d, 2H, J=8.4 Hz), 6.22 (dd, 1H, J=3.3 Hz, 14.2 Hz), 5.36 (s, 1H), 4.24 (dd, 2H, J=4.6 Hz, 11.8 Hz), 3.52 (d, 2H, J=11.8 Hz), 2.17-2.07 (m, 1H), 1.38-1.29 (m, 2H), 1.12-1.06 (m, 2H), 0.93 (t, 3H, J=7.3 Hz).



19F-NMR (δ ppm; CFCl3): −62.07 (t, 2F, J=28.5 Hz), −96.17 (dd, 1F, J=14.2 Hz, 73.0 Hz), −110.62 (dt, 2F, J=10.1 Hz, 28.5 Hz), −118.04 (dd, 2F, J=3.3 Hz, 73.0 Hz), −126.66 (dd, 2F, J=2.0 Hz, 8.4 Hz).


Physical properties of compound (No. 70) were as described below.


Transition temperature: C 31.3 I. TNI=6.4° C.; η=27.9 mPa·s; Δn=0.0837; Δ∈=33.7.


Example 6
Synthesis of Compound (No. 148)



embedded image


Compound (No. 148) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.61 (d, 2H, J=8.2 Hz), 7.33 (d, 2H, J=8.2 Hz), 6.93 (d, 2H, J=8.6 Hz), 6.24 (dd, 1H, J=3.5 Hz, 14.4 Hz), 2.54 (tt, 1H, J=3.2 Hz, 12.2 Hz), 1.98-1.92 (m, 2H), 1.92-1.86 (m, 2H), 1.83-1.74 (m, 4H), 1.52-1.42 (m, 2H), 1.38-1.29 (m, 2H), 1.22-1.14 (m, 6H), 1.12-0.98 (m, 3H), 0.94-0.84 (m, 2H), 0.90 (t, 3H, J=7.4 Hz).



19F-NMR (δ ppm; CFCl3): −66.51 (s, 2F), −96.15-−96.35 (m, 1F), −118.12 (dd, 1F, J=3.5 Hz, 74.2 Hz), −127.01 (d, 2F, J=8.6 Hz).


Physical properties of compound (No. 148) were as described below.


Transition temperature: C 76.7 C 82.2 C 90.7 N 211.4 I. TNI=161.7° C.; η=42.5 mPa·s; Δn=0.137; Δ∈=19.6.


Example 7
Synthesis of Compound (No. 151)



embedded image


Compound (No. 151) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 6.95 (d, 2H, J=8.5 Hz), 6.85 (d, 2H, J=10.8 Hz), 6.24 (dd, 1H, J=3.3 Hz, 14.5 Hz), 2.49 (tt, 1H, J=3.2 Hz, 12.2 Hz), 1.97-1.85 (m, 4H), 1.83-1.72 (m, 4H), 1.45-1.29 (m, 4H), 1.22-0.97 (m, 9H), 0.93-0.84 (m, 2H), 0.90 (t, 3H, J=7.3 Hz).



19F-NMR (δ ppm; CFCl3): −62.09 (t, 2F, J=27.8 Hz), −96.10-−96.29 (m, 1F), −112.11 (dt, 2F, J=10.8 Hz, 27.8 Hz), −118.03 (dd, 1F, J=3.3 Hz, 73.1 Hz), −126.82 (d, 2F, J=8.5 Hz).


Physical properties of compound (No. 151) were as described below.


Transition temperature: C 54.4 C 75.9 N 183.3 I. TNI=124.4° C.; η=53.2 mPa·s; Δn=0.1237; Δ∈=27.6.


Example 8
Synthesis of Compound (No. 155)



embedded image


Compound (No. 155) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.73 (d, 2H, J=8.3 Hz), 7.68 (d, 2H, J=8.3 Hz), 7.54 (d, 2H, J=8.2 Hz), 7.32 (d, 2H, J=8.2 Hz), 6.94 (d, 2H, J=8.4 Hz), 6.23 (dd, 1H, J=3.2 Hz, 14.0 Hz), 2.53 (tt, 1H, J=3.2 Hz; 12.2 Hz), 1.97-1.85 (m, 4H), 1.54-1.44 (m, 2H), 1.41-1.27 (m, 3H), 1.27-1.20 (m, 2H), 1.13-1.02 (m, 2H), 0.91 (t, 3H, J=7.1 Hz).



19F-NMR (δ ppm; CFCl3): −66.54 (s, 2F), −96.10-−96.31 (m, 1F), −118.08 (dd, 1F, J=3.2 Hz, 73.0 Hz), −126.80 (d, 2F, J=8.4 Hz).


Physical properties of compound (No. 155) were as described below.


Transition temperature: C 67.3 C 80.2 SG 98.6 SF 106 SB 109 SA 152.4 N 208.5 I. TNI=163.7° C.; η=48.7 mPa·s; Δn=0.177; Δ∈=21.8.


Example 9
Synthesis of Compound (No. 157)



embedded image


Compound (No. 157) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.49 (d, 2H, J=8.3 Hz), 7.32 (d, 2H, J=8.3 Hz), 7.20 (d, 2H, J=10.5 Hz), 6.95 (d, 2H, J=8.4 Hz), 6.22 (dd, 1H, J=3.3 Hz, 14.1 Hz), 2.53 (tt, 1H, J=3.1 Hz, 12.1 Hz), 1.96-1.86 (m, 4H), 1.54-1.42 (m, 2H), 1.41-1.28 (m, 3H), 1.28-1.20 (m, 2H), 1.13-1.02 (m, 2H), 0.91 (t, 3H, J=7.4 Hz).



19F-NMR (δ ppm; CFCl3): −61.95 (t, 2F, J=27.8 Hz), −96.08-96.29 (m, 1F), −111.12 (dt, 2F, J=10.5 Hz, 27.7 Hz), −118.11 (dd, 1F, J=3.3 Hz, 73.0 Hz), −126.71 (d, 2F, J=8.4 Hz).


Physical properties of compound (No. 157) were as described below.


Transition temperature: C 81 N 164 I. TNI=94.4° C.; η=34.9 mPa·s; Δn=0.1503; Δ∈=27.23.


Example 10
Synthesis of Compound (No. 163)



embedded image


Compound (No. 163) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.54 (d, 2H, J=8.2 Hz), 7.49 (d, 2H, J=4.3 Hz), 7.42 (d, 1H, J=12.3 Hz), 7.32-7.23 (m, 4H), 6.97 (d, 2H, J=8.2 Hz), 6.24 (dd, 1H, J=3.2 Hz, 14.3 Hz), 2.65 (t, 3H, J=7.7 Hz), 1.69 (tq, 2H, J=7.7 Hz, 7.4 Hz), 0.98 (d, 3H, J=7.4 Hz).



19F-NMR (δ ppm; CFCl3): −62.11 (t, 2F, J=27.8 Hz), −96.02-96.24 (m, 1F), −111.16 (dt, 2F, J=11.0 Hz, 27.9 Hz), −118.03 (dd, 1F, J=3.2 Hz, 73.0 Hz), −117.30−−117.37 (m, 1F), −126.64 (d, 2F, J=8.2 Hz).


Physical properties of compound (No. 163) were as described below.


Transition temperature: C 86.2 SA 126.9 N 156.9. TNI=104.4° C.; η=53.9 mPa·s; Δn=0.2103; Δ∈=39.23.


Example 11
Synthesis of Compound (No. 205)



embedded image


Compound (No. 205) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.38 (dd, 1H, J=7.9 Hz, 7.9 Hz), 7.25-7.18 (m, 4H), 6.95 (d, 2H, J=8.4 Hz), 6.23 (dd, 1H, J=3.1 Hz, 14.1 Hz), 4.32-4.30 (m, 1H), 4.11 (ddd, 1H, J=1.8 Hz, 4.1 Hz, 11.2 Hz), 3.22 (dd, 1H, J=11.2 Hz, 11.2 Hz), 2.05-1.98 (m, 1H), 1.95-1.88 (m, 1H), 1.74-1.63 (m, 1H), 1.62-1.52 (m, 1H), 1.45-1.24 (m, 3H), 1.23-1.09 (m, 2H), 0.93 (t, 3H, J=7.3 Hz).



19F-NMR (δ ppm; CFCl3): −62.14 (t, 2F, J=27.8 Hz), −96.04-96.25 (m, 1F), −111.28 (dt, 2F, J=11.6 Hz, 27.8 Hz), −117.56 (dd, 1F, J=7.9 Hz, 12.3 Hz), −117.99 (dd, 1F, J=3.1 Hz, 73.0 Hz), −126.66 (dd, 2F, J=2.3 Hz, 8.4 Hz).


Physical properties of compound (No. 205) were as described below.


Transition temperature: C 63.2 N 128.2 I. TNI=95.0° C.; η=55.9 mPa·s; Δn=0.1437; Δ∈=37.4.


Example 12
Synthesis of Compound (No. 212)



embedded image


Compound (No. 212) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.45 (dd, 1H, J=7.4 Hz, 7.4 Hz), 7.00 (d, 1H, J=7.4 Hz), 7.38 (d, 1H, J=10.1 Hz), 7.22 (d, 2H, J=10.6 Hz), 6.98 (d, 2H, J=8.4 Hz), 6.25 (dd, 1H, J=3.2 Hz, 14.4 Hz), 5.47 (s, 1H), 4.28 (dd, 2H, J=4.5 Hz, 11.6 Hz), 3.58 (dd, 2H, J=11.6 Hz, 11.6 Hz), 2.24-2.13 (m, 1H), 1.43-1.33 (m, 2H), 1.17-1.10 (m, 2H), 0.96 (t, 3H, J=7.3 Hz).



19F-NMR (δ ppm; CFCl3): −62.17 (d, 2F, J=27.9 Hz), −96.04-−96.24 (m, 1F), −111.11 (dt, 2F, J=10.6 Hz, 27.9 Hz), −117.33 (dd, 1F, J=7.4 Hz, 11.6 Hz), −117.98 (dd, 1F, J=3.2 Hz, 73.0 Hz), −126.64 (d, 2F, J=8.4 Hz).


Physical properties of compound (No. 212) were as described below.


Transition temperature: C 78.4 N 129.9 I. TNI=101.7° C.; η=64.2 mPa·s; Δn=0.157; Δ∈=41.7.


Example 13
Synthesis of Compound (No. 446)



embedded image


Compound (No. 446) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 6.84 (d, 2H, J=8.4 Hz), 2.05-1.92 (m, 3H), 1.88-1.81 (m, 2H), 1.79-1.67 (m, 4H), 1.38-1.24 (m, 4H), 1.19-1.11 (m, 3H), 1.10-0.91 (m, 6H), 0.90-0.80 (m, 2H), 0.87 (t, 3H, J=7.5 Hz).



19F-NMR (δ ppm; CFCl3): −79.38 (d, 2F, J=8.9 Hz), −121.39-121.75 (dd, 1F, J=65.2 Hz, 103.8 Hz), −125.39-−125.88 (m, 1F), −126.87-−126.94 (m, 1F), −135.67-−136.09 (m, 1F).


Physical properties of compound (No. 446) were as described below.


Transition temperature: C 32.1 N 93.4 I. TNI=73.7° C.; η=53.2 mPa·s; Δn=0.077; Δ∈=13.2.


Example 14
Synthesis of Compound (No. 694)



embedded image


Compound (No. 694) was prepared in a manner similar to the operations in Example 1.



1H-NMR (δ ppm; CDCl3): 7.81 (d, 2H, J=8.3 Hz), 7.72 (d, 2H, J=8.3 Hz), 7.57 (d, 2H, J=8.1 Hz), 7.41 (dd, 1H, J=8.1 Hz), 7.32 (d, 2H, J=8.1 Hz), 7.23-7.15 (m, 4H), 6.33 (dd, 1H, J=3.2 Hz, 14.1 Hz), 2.68 (t, 2H, J=7.6 Hz), 1.72 (tq, 2H, J=7.6 Hz, J=7.5 Hz), 1.01 (t, 3H, J=7.5 Hz).



19F-NMR (δ ppm; CFCl3): −66.07 (s, 2F), −96.23-−96.44 (m, 1F), −115.00 (dd, 1F, J=8.1 Hz), −118.14 (dd, 1F, J=3.2 Hz, 73.2 Hz), −128.61 (d, 2F, J=9.7 Hz).


Physical properties of compound (No. 694) were as described below.


Transition temperature: C 106.3 SA 153.3 N 181.7. TNI=131.7° C.; η=49.2 mPa·s; Δn=0.2103; Δ∈=29.23.


Compounds (No. 1) to (No. 696) shown below can be prepared in a manner similar to the synthesis method described in Example 1.












Formula 53








No.






 1


embedded image







 2


embedded image







 3


embedded image







 4


embedded image







 5


embedded image







 6


embedded image







 7


embedded image







 8


embedded image







 9


embedded image







10


embedded image







11


embedded image







12


embedded image







13


embedded image







14


embedded image







15


embedded image







16


embedded image







17


embedded image







18


embedded image







19


embedded image







20


embedded image







21


embedded image







22


embedded image







23


embedded image







24


embedded image





















Formula 54








No.









25


embedded image







26


embedded image







27


embedded image







28


embedded image







29


embedded image







30


embedded image







31


embedded image







32


embedded image







33


embedded image







34


embedded image







35


embedded image







36


embedded image







37


embedded image







38


embedded image







39


embedded image







40


embedded image







41


embedded image







42


embedded image







43


embedded image







44


embedded image







45


embedded image







46


embedded image







47


embedded image







48


embedded image





















Formula 55








No.






49


embedded image







50


embedded image







51


embedded image







52


embedded image







53


embedded image







54


embedded image







55


embedded image







56


embedded image







57


embedded image







58


embedded image







59


embedded image







60


embedded image







61


embedded image







62


embedded image







63


embedded image







64


embedded image







65


embedded image







66


embedded image







67


embedded image







68


embedded image







69


embedded image







70


embedded image







71


embedded image







72


embedded image





















Formula 56








No.






73


embedded image







74


embedded image







75


embedded image







76


embedded image







77


embedded image







78


embedded image







79


embedded image







80


embedded image







81


embedded image







82


embedded image







83


embedded image







84


embedded image







85


embedded image







86


embedded image







87


embedded image







88


embedded image







89


embedded image







90


embedded image







91


embedded image







92


embedded image







93


embedded image







94


embedded image







95


embedded image







96


embedded image





















Formula 57








No.






 97


embedded image







 98


embedded image







 99


embedded image







100


embedded image







101


embedded image







102


embedded image







103


embedded image







104


embedded image







105


embedded image







106


embedded image







107


embedded image







108


embedded image







109


embedded image







110


embedded image







111


embedded image







112


embedded image







113


embedded image







114


embedded image







115


embedded image







116


embedded image







117


embedded image







118


embedded image







119


embedded image







120


embedded image





















Formula 58








No.






121


embedded image







122


embedded image







123


embedded image







124


embedded image







125


embedded image







126


embedded image







127


embedded image







128


embedded image







129


embedded image







130


embedded image







131


embedded image







132


embedded image







133


embedded image







134


embedded image







135


embedded image







136


embedded image







137


embedded image







138


embedded image







139


embedded image







140


embedded image







141


embedded image







142


embedded image







143


embedded image







144


embedded image





















Formula 59








No.






145


embedded image







146


embedded image







147


embedded image







148


embedded image







149


embedded image







150


embedded image







151


embedded image







152


embedded image







153


embedded image







154


embedded image







155


embedded image







156


embedded image







157


embedded image







158


embedded image







159


embedded image







160


embedded image







161


embedded image







162


embedded image







163


embedded image







164


embedded image







165


embedded image







166


embedded image







167


embedded image







168


embedded image





















Formula 60








No.






169


embedded image







170


embedded image







171


embedded image







172


embedded image







173


embedded image







174


embedded image







175


embedded image







176


embedded image







177


embedded image







178


embedded image







179


embedded image







180


embedded image







181


embedded image







182


embedded image







183


embedded image







184


embedded image







185


embedded image







186


embedded image







187


embedded image







188


embedded image







189


embedded image







190


embedded image







191


embedded image







192


embedded image





















Formula 61








No.






193


embedded image







194


embedded image







195


embedded image







196


embedded image







197


embedded image







198


embedded image







199


embedded image







200


embedded image







201


embedded image







202


embedded image







203


embedded image







204


embedded image







205


embedded image







206


embedded image







207


embedded image







208


embedded image







209


embedded image







210


embedded image







211


embedded image







212


embedded image







213


embedded image







214


embedded image







215


embedded image







216


embedded image





















Formula 62








No.






217


embedded image







218


embedded image







219


embedded image







220


embedded image







221


embedded image







222


embedded image







223


embedded image







224


embedded image







225


embedded image







226


embedded image







227


embedded image







228


embedded image







229


embedded image







230


embedded image







232


embedded image







232


embedded image







233


embedded image







234


embedded image







235


embedded image







236


embedded image







237


embedded image







238


embedded image







239


embedded image







240


embedded image





















Formula 63








No.






241


embedded image







242


embedded image







243


embedded image







244


embedded image







245


embedded image







246


embedded image







247


embedded image







248


embedded image







249


embedded image







250


embedded image







251


embedded image







252


embedded image







253


embedded image







254


embedded image







255


embedded image







256


embedded image







257


embedded image







258


embedded image







259


embedded image







260


embedded image







261


embedded image







262


embedded image







263


embedded image







264


embedded image





















Formula 64








No.






265


embedded image







266


embedded image







257


embedded image







268


embedded image







269


embedded image







270


embedded image







271


embedded image







272


embedded image







273


embedded image







274


embedded image







275


embedded image







276


embedded image







277


embedded image







278


embedded image







279


embedded image







280


embedded image







281


embedded image







282


embedded image







283


embedded image







284


embedded image







285


embedded image







286


embedded image







287


embedded image







288


embedded image





















Formula 65








No.






289


embedded image







290


embedded image







291


embedded image







292


embedded image







293


embedded image







294


embedded image







295


embedded image







296


embedded image







297


embedded image







298


embedded image







299


embedded image







300


embedded image







301


embedded image







302


embedded image







303


embedded image







304


embedded image







305


embedded image







306


embedded image







307


embedded image







308


embedded image







309


embedded image







310


embedded image







311


embedded image







312


embedded image





















Formula 66








No.






313


embedded image







314


embedded image







315


embedded image







316


embedded image







317


embedded image







318


embedded image







319


embedded image







320


embedded image







321


embedded image







322


embedded image







323


embedded image







324


embedded image







325


embedded image







326


embedded image







327


embedded image







328


embedded image







329


embedded image







330


embedded image







331


embedded image







332


embedded image







333


embedded image







334


embedded image







335


embedded image







336


embedded image





















Formula 67








No.






337


embedded image







338


embedded image







339


embedded image







340


embedded image







341


embedded image







342


embedded image







343


embedded image







344


embedded image







345


embedded image







346


embedded image







347


embedded image







348


embedded image







349


embedded image







350


embedded image







351


embedded image







352


embedded image







353


embedded image







354


embedded image







355


embedded image







356


embedded image







357


embedded image







358


embedded image







359


embedded image







360


embedded image





















Formula 68








No.






361


embedded image







362


embedded image







363


embedded image







364


embedded image







365


embedded image







366


embedded image







367


embedded image







368


embedded image







369


embedded image







370


embedded image







371


embedded image







372


embedded image







373


embedded image







374


embedded image







375


embedded image







376


embedded image







377


embedded image







378


embedded image







379


embedded image







380


embedded image







381


embedded image







382


embedded image







383


embedded image







384


embedded image





















Formula 69










No.








385


embedded image









386


embedded image









387


embedded image









388


embedded image









389


embedded image









390


embedded image









391


embedded image









392


embedded image









393


embedded image









394


embedded image









395


embedded image









396


embedded image









397


embedded image









398


embedded image









399


embedded image









400


embedded image









401


embedded image









402


embedded image









403


embedded image









404


embedded image









405


embedded image









406


embedded image









407


embedded image









408


embedded image






















Formula 70










No.








409


embedded image









410


embedded image









411


embedded image









412


embedded image









413


embedded image









414


embedded image









415


embedded image









416


embedded image









417


embedded image









418


embedded image









419


embedded image









420


embedded image









421


embedded image









422


embedded image









423


embedded image









424


embedded image









425


embedded image









426


embedded image









427


embedded image









428


embedded image









429


embedded image









430


embedded image









431


embedded image









432


embedded image






















Formula 71








No.






433


embedded image







434


embedded image







435


embedded image







436


embedded image







437


embedded image







438


embedded image







439


embedded image







440


embedded image







441


embedded image







442


embedded image







443


embedded image







444


embedded image







445


embedded image







446


embedded image







447


embedded image







448


embedded image







449


embedded image







450


embedded image







451


embedded image







452


embedded image







453


embedded image







454


embedded image







455


embedded image







456


embedded image





















Formula 72








No.






457


embedded image







458


embedded image







459


embedded image







460


embedded image







461


embedded image







462


embedded image







463


embedded image







464


embedded image







465


embedded image







466


embedded image







467


embedded image







468


embedded image







469


embedded image







470


embedded image







471


embedded image







472


embedded image







473


embedded image







474


embedded image







475


embedded image







476


embedded image







477


embedded image







478


embedded image







479


embedded image







480


embedded image





















Formula 73








No.






481


embedded image







482


embedded image







483


embedded image







484


embedded image







485


embedded image







486


embedded image







487


embedded image







488


embedded image







489


embedded image







490


embedded image







491


embedded image







492


embedded image







493


embedded image







494


embedded image







495


embedded image







496


embedded image







497


embedded image







498


embedded image







499


embedded image







500


embedded image







501


embedded image







502


embedded image







503


embedded image







504


embedded image





















Formula 74








No.






505


embedded image







506


embedded image







507


embedded image







508


embedded image







509


embedded image







510


embedded image







511


embedded image







512


embedded image







513


embedded image







514


embedded image







515


embedded image







516


embedded image







517


embedded image







518


embedded image







519


embedded image







520


embedded image







521


embedded image







522


embedded image







523


embedded image







524


embedded image







525


embedded image







526


embedded image







527


embedded image







528


embedded image





















Formula 75








No.






529


embedded image







530


embedded image







531


embedded image







532


embedded image







533


embedded image







534


embedded image







535


embedded image







536


embedded image







537


embedded image







538


embedded image







539


embedded image







540


embedded image







541


embedded image







542


embedded image







543


embedded image







544


embedded image







545


embedded image







546


embedded image







547


embedded image







548


embedded image







549


embedded image







550


embedded image







551


embedded image







552


embedded image





















Formula 76








No.






553


embedded image







554


embedded image







555


embedded image







556


embedded image







557


embedded image







558


embedded image







559


embedded image







560


embedded image







561


embedded image







562


embedded image







563


embedded image







564


embedded image







565


embedded image







566


embedded image







567


embedded image







568


embedded image







569


embedded image







570


embedded image







571


embedded image







572


embedded image







573


embedded image







574


embedded image







575


embedded image







576


embedded image





















Formula 77








No.






577


embedded image







578


embedded image







579


embedded image







580


embedded image







581


embedded image







582


embedded image







583


embedded image







584


embedded image







585


embedded image







586


embedded image







587


embedded image







588


embedded image







589


embedded image







590


embedded image







591


embedded image







592


embedded image







593


embedded image







594


embedded image







595


embedded image







596


embedded image







597


embedded image







598


embedded image







599


embedded image







600


embedded image





















Formula 78








No.






601


embedded image







602


embedded image







603


embedded image







604


embedded image







605


embedded image







606


embedded image







607


embedded image







608


embedded image







609


embedded image







610


embedded image







611


embedded image







612


embedded image







613


embedded image







614


embedded image







615


embedded image







616


embedded image







617


embedded image







618


embedded image







619


embedded image







620


embedded image







621


embedded image







622


embedded image







623


embedded image







624


embedded image





















Formula 79








No.






625


embedded image







626


embedded image







627


embedded image







628


embedded image







629


embedded image







630


embedded image







631


embedded image







632


embedded image







633


embedded image







634


embedded image







635


embedded image







636


embedded image







637


embedded image







638


embedded image







639


embedded image







640


embedded image







641


embedded image







642


embedded image







643


embedded image







644


embedded image







645


embedded image







646


embedded image







647


embedded image







648


embedded image





















Formula 80








No.






649


embedded image







650


embedded image







651


embedded image







652


embedded image







653


embedded image







654


embedded image







655


embedded image







656


embedded image







657


embedded image







658


embedded image







659


embedded image







660


embedded image







661


embedded image







662


embedded image







663


embedded image







664


embedded image







665


embedded image







666


embedded image







667


embedded image







668


embedded image







669


embedded image







670


embedded image







671


embedded image







672


embedded image





















Formula 81








No.






673


embedded image







674


embedded image







675


embedded image







676


embedded image







677


embedded image







678


embedded image







679


embedded image







680


embedded image







681


embedded image







682


embedded image







683


embedded image







684


embedded image







685


embedded image







686


embedded image







687


embedded image







688


embedded image







689


embedded image







690


embedded image







691


embedded image







692


embedded image







693


embedded image







694


embedded image







695


embedded image







696


embedded image











Comparative Example 1

As a comparative compound, compound (A) was prepared in a manner similar to the operations in Example 1. The compound corresponds to compound (S-3) described in DE 19531165 A (Patent literature No. 10).




embedded image


Physical properties of comparative compound (A) were as described below.


Transition temperature: TNI=41.7° C.









TABLE 1





Physical properties of compound (No. 13) and comparative compound (A)



















embedded image







Maximum
105.7° C.


temperature (TNI)








embedded image







Maximum
41.7° C.


temperature (TNI)









Physical properties of compound (No. 13) obtained in Example 1 and comparative compound (A) were summarized in Table 1. Table 1 represents that compound (No. 13) is superior to comparative compound (A) in view of a higher maximum temperature.


1-2. Examples of Composition (1)

Liquid crystal composition (1) of the invention will be explained in detail by way of Examples. The invention is not limited by the Examples described below. Compounds in Examples are described using symbols based on definitions in Table 2 below. In Table 2, a configuration of 1,4-cyclohexylene is trans. In Examples, a parenthesized number next to a symbolized compound corresponds to the number of the compound. A symbol (−) means any other liquid crystal compound. A ratio (percentage) of the liquid crystal compounds is expressed in terms of weight percent (% by weight) based on the total weight of the liquid crystal composition. Values of physical properties of the composition were summarized in a last part. Physical properties were measured according to the methods described above, and measured values were described as were without extrapolation of the measured values.









TABLE 2





Table Method for Description of Compounds using Symbols


R—(A1)—Z1— . . . —Zn—(An)—R′
















1) Left-terminal Group R—
Symbol





CnH2n+1
n-


CnH2n+1O—
nO—


CmH2m+1OCnH2n
mOn—


CH2═CH—
V—


CnH2n+1—CH═CH—
nV—


CH2═CH—CnH2n
Vn—


CmH2m+1—CH═CH—CnH2n
mVn—


CF2═CH—
VFF—


CF2═CH—CnH2n
VFFn—





2). Right-terminal Group —R′
Symbol





—CnH2n+1
-n


—OCnH2n+1
—On


—COOCH3
—EMe


—CH═CH2
—V


—CH═CH—CnH2n+1
—Vn


—CnH2n—CH═CH2
—nV


—CmH2m—CH═CH—CnH2n + 1
—mVn


—CH═CF2
—VFF


—OCH═CF2
—OVFF


—F
—F


—Cl
—CL


—OCF3
—OCF3


—OCF2H
—OCF2H


—CF3
—CF3


—CN
—C





3). Bonding Group —Zn
Symbol





—CnH2n
n


—COO—
E


—CH═CH—
V


—CH2O—
1O


—OCH2
O1


—CF2O—
X


—C≡C—
T





4) Ring Structure —An
Symbol







embedded image


H







embedded image


B







embedded image


B(F)







embedded image


B(2F)







embedded image


B(F,F)







embedded image


B(2F,5F)







embedded image


B(2F,3F)







embedded image


Py







embedded image


G







embedded image


dh







embedded image


Dh










5) Examples of Description







embedded image









embedded image









embedded image









embedded image











Example 15
Use Example 1












TABLE 3









3-HHXB(F,F)-OVFF
(No. 13)
6%



5-HB-CL
(2-2)
16%



3-HH-4
(12-1) 
12%



3-HH-5
(12-1) 
4%



3-HHB-F
(3-1)
4%



3-HHB-CL
(3-1)
3%



4-HHB-CL
(3-1)
4%



3-HHB(F)-F
(3-2)
10%



4-HHB(F)-F
(3-2)
9%



5-HHB(F)-F
(3-2)
9%



7-HHB(F)-F
(3-2)
8%



5-HBB(F)-F
 (3-23)
4%



1O1-HBBH-5
(14-1) 
3%



3-HHBB(F,F)-F
(4-6)
2%



5-HHBB(F,F)-F
(4-6)
3%



3-HH2BB(F,F)-F
 (4-15)
3%







NI = 110.4° C.;



Δn = 0.088;



Δε = 4.1;



η = 16.1 mPa · s.






Example 16
Use Example 2












TABLE 4









3-dhB(F)B(F,F)XB(F,F)-OVFF
(No. 205)
7%



3-HHB(F,F)-F
(3-2) 
9%



3-H2HB(F,F)-F
(3-15)
8%



4-H2HB(F,F)-F
(3-15)
8%



5-H2HB(F,F)-F
(3-15)
8%



3-HBB(F,F)-F
(3-24)
18%



5-HBB(F,F)-F
(3-24)
16%



3-H2BB(F,F)-F
(3-27)
10%



5-HHBB(F,F)-F
(4-6) 
3%



5-HHEBB-F
(4-17)
2%



3-HH2BB(F,F)-F
(4-15)
3%



1O1-HBBH-4
(14-1) 
4%



1O1-HBBH-5
(14-1) 
4%







NI = 100.7° C.;



Δn = 0.118;



Δε = 10.8;



η = 36.2 mPa · s.






Example 17
Use Example 3












TABLE 5









3-HHXB(F,F)-OVFF
(No. 13)
7%



5-HB-F
(2-2)
9%



6-HB-F
(2-2)
9%



7-HB-F
(2-2)
7%



2-HHB-OCF3
(3-1)
7%



3-HHB-OCF3
(3-1)
7%



4-HHB-OCF3
(3-1)
7%



5-HHB-OCF3
(3-1)
5%



3-HH2B-OCF3
(3-4)
4%



5-HH2B-OCF3
(3-4)
4%



3-HHB(F,F)-OCF2H
(3-3)
4%



3-HHB(F,F)-OCF3
(3-3)
5%



3-HH2B(F)-F
(3-5)
3%



3-HBB(F)-F
 (3-23)
8%



5-HBB(F)-F
 (3-23)
8%



5-HBBH-3
(14-1) 
3%



3-HB(F)BH-3
(14-2) 
3%







NI = 90.3° C.;



Δn = 0.093;



Δε = 5.3;



η = 15.8 mPa · s.






A pitch when adding 0.25 part of (Op-05) was added to 100 parts of the composition was 59.8 micrometers.


Example 18
Use Example 4












TABLE 6









3-dhB(F)B(F,F)XB(F,F)-OVFF
(No. 205)
8%



5-HB-CL
(2-2) 
8%



3-HH-4
(12-1) 
8%



3-HHB-1
(13-1) 
2%



3-HHB(F,F)-F
(3-3) 
8%



3-HBB(F,F)-F
(3-24)
20%



5-HBB(F,F)-F
(3-24)
15%



3-HHEB(F,F)-F
(3-12)
8%



4-HHEB(F,F)-F
(3-12)
3%



5-HHEB(F,F)-F
(3-12)
3%



2-HBEB(F,F)-F
(3-39)
3%



3-HBEB(F,F)-F
(3-39)
5%



5-HBEB(F,F)-F
(3-39)
3%



3-HHBB(F,F)-F
(4-6) 
6%







NI = 81.1° C.;



Δn = 0.108;



Δε = 11.2;



η = 25.5 mPa · s.






Example 19
Use Example 5












TABLE 7









3-HHXB(F,F)-OVFF
(No. 13)
8%



3-HB-CL
(2-2)
3%



5-HB-CL
(2-2)
4%



3-HHB-OCF3
(3-1)
5%



3-H2HB-OCF3
 (3-13)
5%



5-H4HB-OCF3
 (3-19)
15%



V-HHB(F)-F
(3-2)
5%



3-HHB(F)-F
(3-2)
5%



5-HHB(F)-F
(3-2)
5%



3-H4HB(F,F)-CF3
 (3-21)
8%



5-H4HB(F,F)-CF3
 (3-21)
10%



5-H2HB(F,F)-F
 (3-15)
5%



5-H4HB(F,F)-F
 (3-21)
7%



2-H2BB(F)-F
 (3-26)
5%



3-H2BB(F)-F
 (3-26)
5%



3-HBEB(F,F)-F
 (3-39)
5%







NI = 74.2° C.;



Δn = 0.096;



Δε = 9.0;



η = 26.1 mPa · s.






Example 20
Use Example 6












TABLE 8









3-dhB(F)B(F,F)XB(F,F)-OVFF
(No. 205)
6%



5-HB-CL
(2-2)
14%



7-HB(F,F)-F
(2-4)
3%



3-HH-4
(12-1) 
10%



3-HH-5
(12-1) 
5%



3-HB-O2
(12-5) 
12%



3-HHB-1
(13-1) 
8%



3-HHB-O1
(13-1) 
5%



2-HHB(F)-F
(3-2)
7%



3-HHB(F)-F
(3-2)
7%



5-HHB(F)-F
(3-2)
7%



3-HHB(F,F)-F
(3-3)
6%



3-H2HB(F,F)-F
 (3-15)
5%



4-H2HB(F,F)-F
 (3-15)
5%







NI = 76.1° C.;



Δn = 0.078;



Δε = 4.8;



η = 17.3 mPa · s.






Example 21
Use Example 7












TABLE 9









3-HHXB(F,F)-OVFF
(No. 13)
7%



5-HB-CL
(2-2) 
3%



7-HB(F)-F
(2-3) 
7%



3-HH-4
(12-1) 
9%



3-HH-EMe
(12-2) 
23%



3-HHEB-F
(3-10)
8%



5-HHEB-F
(3-10)
8%



3-HHEB(F,F)-F
(3-12)
10%



4-HHEB(F,F)-F
(3-12)
5%



4-HGB(F,F)-F
 (3-103)
3%



5-HGB(F,F)-F
 (3-103)
6%



3-H2GB(F,F)-F
 (3-106)
5%



5-GHB(F,F)-F
 (3-109)
6%







NI = 84.6° C.;



Δn = 0.067;



Δε = 5.7;



η = 18.6 mPa · s.






Example 22
Use Example 8












TABLE 10









3-dhB(F)B(F,F)XB(F,F)-OVFF
(No. 205)
6%



3-HB-O2
(12-5) 
10%



5-HB-CL
(2-2) 
13%



3-HBB(F,F)-F
(3-24)
7%



3-PyB(F)-F
(2-15)
10%



5-PyB(F)-F
(2-15)
10%



3-PyBB-F
(3-80)
10%



4-PyBB-F
(3-80)
10%



5-PyBB-F
(3-80)
10%



5-HBB(F)B-2
(14-5) 
7%



5-HBB(F)B-3
(14-5) 
7%







NI = 91.0° C.;



Δn = 0.184;



Δε = 10.0;



η = 39.6 mPa · s.






Example 23
Use Example 9












TABLE 11









3-HHXB(F,F)-OVFF
(No. 13)
3%



3-dhB(F)B(F,F)XB(F,F)-OVFF
(No. 251)
4%



3-HB-C
(5-1)
5%



3-BEB(F)-C
 (5-14)
4%



1V2-BEB(F)-C
 (5-14)
12%



3-HHB-C
 (5-28)
6%



3-HHB(F)-C
 (5-29)
6%



3-HB-O2
(12-5) 
11%



2-HH-3
(12-1) 
11%



3-HH-4
(12-1) 
10%



3-HHB-1
(13-1) 
8%



3-HHB-O1
(13-1) 
4%



3-H2BTB-2
(13-17)
4%



3-H2BTB-3
(13-17)
4%



3-H2BTB-4
(13-17)
4%



3-HB(F)TB-2
(13-18)
4%







NI = 105.1° C.;



Δn = 0.132;



Δε = 10.7;



η = 21.8 mPa · s.






Example 24
Use Example 10












TABLE 12









3-HHXB(F,F)-OVFF
(No. 13)
4%



3-dhB(F)B(F,F)XB(F,F)-OVFF
(No. 251)
4%



3-HB-O1
(12-5) 
15%



3-HH-4
(12-1) 
5%



3-HB(2F,3F)-O2
(6-1)
12%



5-HB(2F,3F)-O2
(6-1)
12%



2-HHB(2F,3F)-1
(7-1)
12%



3-HHB(2F,3F)-1
(7-1)
10%



3-HHB(2F,3F)-O2
(7-1)
7%



5-HHB(2F,3F)-O2
(7-1)
13%



3-HHB-1
(13-1) 
6%







NI = 78.8° C.;



Δn = 0.085;



Δε = −2.3;



η = 33.1 mPa · s.






Although the invention has been described and illustrated with a certain degree of particularity, it is understood that the disclosure has been made only by way of example, and that numerous changes in the conditions and order of steps can be resorted to by those skilled in the art without departing from the spirit and scope of the invention.


INDUSTRIAL APPLICABILITY

A liquid crystal compound of the invention has a high stability to heat, light and so forth, a high clearing point, a low minimum temperature of a liquid crystal phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy, a suitable elastic constant and an excellent solubility in other liquid crystal compounds. A liquid crystal composition of the invention contains the compound, and has a high maximum temperature of a nematic phase, a low minimum temperature of the nematic phase, a small viscosity, a suitable optical anisotropy, a large dielectric anisotropy and a suitable elastic constant. The composition has a suitable balance regarding at least two of physical properties. A liquid crystal display device of the invention includes the composition, and has a wide temperature range in which the device can be used, a short response time, a large voltage holding ratio, a large contrast ratio and a long service life. Accordingly, the device can be widely utilized for a liquid crystal display device to be used for a personal computer, a television and so forth.

Claims
  • 1. A compound represented by formula (1):
  • 2. The compound according to claim 1, wherein R1 is alkyl having 1 to 20 carbons or alkenyl having 2 to 20 carbons;ring A1, and ring A3 are independently 1,4-cyclohexylene, 1,4-phenylene, 2-fluoro-1,4-phenylene, 2,6-difluoro-1,4-phenylene, tetrahydropyran-2,5-diyl or 1,3-dioxane-2,5-diyl;Z1 and Z3 are independently a single bond, —CH═CH— or —CF2O—, andL1, L2 and L3 are independently hydrogen or fluorine.
  • 3. The compound according to claim 1, wherein ring A2 2-fluoro-1,4-phenylene or 2,6-difluoro-1,4-phenylene.
  • 4. The compound according to claim 1, wherein Z1 is a single bond.
  • 5. The compound according to claim 1, wherein n is 0.
  • 6. A compound represented with any of formula (1-2) to formula (1-4):
  • 7. A compound represented by any one of formula (1-8) to formulas (1-11):
  • 8. A liquid crystal composition containing at least one of the compound according to claim 1.
  • 9. The liquid crystal composition according to claim 8, further containing at least one of compound selected from the group of compounds represented by formulas (2) to (4):
  • 10. The liquid crystal composition according to claim 8, further containing at least one of compound selected from the group of compounds represented by formula (5):
  • 11. The liquid crystal composition according to claim 8, further containing at least one of compound selected from the group of compounds represented by formulas (6) to (1):
  • 12. The liquid crystal composition according to claim 8, further containing at least one of compound selected from the group of compounds represented by formulas (12) to (14):
  • 13. The liquid crystal composition according to claim 8, further containing at least one of compound selected from the group of compounds represented by formulas (12) to (14):
  • 14. The liquid crystal composition according to claim 8, further containing at least one of optically active compound.
  • 15. The liquid crystal composition according to claim 8, further containing at least one of antioxidant and/or ultraviolet light absorber.
  • 16. A liquid crystal display device including the liquid crystal composition according to claim 8.
Priority Claims (1)
Number Date Country Kind
2012-165870 Jul 2012 JP national
US Referenced Citations (9)
Number Name Date Kind
5403512 Bartmann et al. Apr 1995 A
5589102 Bartmann et al. Dec 1996 A
20030230737 Kirsch et al. Dec 2003 A1
20080199635 Hirschmann et al. Aug 2008 A1
20110001090 Wittek et al. Jan 2011 A1
20110140039 Wu et al. Jun 2011 A1
20110242473 Haseba et al. Oct 2011 A1
20120009393 Koehler et al. Jan 2012 A1
20120326085 Wittek et al. Dec 2012 A1
Foreign Referenced Citations (1)
Number Date Country
0 844 229 May 1998 EP
Non-Patent Literature Citations (7)
Entry
English abstract of DE 4445224, Jun. 20, 1996.
English abstract of DE 4428766, Mar. 2, 1995.
English abstract of DE 4326020, Feb. 9, 1995.
English abstract of DE 4434976, Apr. 4, 1996.
English abstract of DE 19525314, Jan. 16, 1997.
English abstract of DE 102007009944, Sep. 20, 2007.
English abstract of JP H8-040952, Feb. 13, 1996.
Related Publications (1)
Number Date Country
20140034876 A1 Feb 2014 US